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Abstract
A major contribution to the onset and development of autoimmune disease is known to come
from infections. An important practical problem is identifying the precise mechanism by which the
breakdown of immune tolerance as a result of immune response to infection leads to autoimmunity.
In this paper, we develop a mathematical model of immune response to a viral infection, which
includes T cells with different activation thresholds, regulatory T cells (Tregs), and a cytokine
mediating immune dynamics. Particular emphasis is made on the role of time delays associated
with the processes of infection and mounting the immune response. Stability analysis of various
steady states of the model allows us to identify parameter regions associated with different types
of immune behaviour, such as, normal clearance of infection, chronic infection, and autoimmune
dynamics. Numerical simulations are used to illustrate different dynamical regimes, and to identify
basins of attraction of different dynamical states. An important result of the analysis is that not
only the parameters of the system, but also the initial level of infection and the initial state of the
immune system determine the progress and outcome of the dynamics.
1 Introduction
An immune system can only be viewed as effective when it can robustly identify and destroy
pathogen-infected cells, while also distinguishing such cells from healthy cells. In the case of
breakdown of immune tolerance, the immune system fails to discriminate between self-antigens
and foreign antigens, which results in autoimmune disease, i.e., undesired destruction of healthy
cells. Under normal conditions, once foreign epitopes are presented on antigen presenting cells
(APCs) to T cells, this results in the proliferation of T cells and eliciting their effector function.
While this mechanism is responsible for a successful clearance of infection, cross-reactivity between
epitopes associated with foreign and self-antigens can lead to a T cell response against healthy host
cells [1, 2].
For many autoimmune diseases, the disease occurs in a specific organ or part of the body, such
as retina in uveitis, central nervous system in multiple sclerosis, or pancreatic β-cells in type-1 dia-
betes [3, 4, 5]. It is extremely difficult to identify the specific causes of autoimmunity in individual
patients, as it usually has contributions from a number of internal and external factors, including
a genetic predisposition, age, previous immune challenges, exposure to pathogens etc., [6, 7, 8, 9].
Even though genetic predisposition is known to play a very significant role, it is believed that
some additional environmental triggers are required for the onset of autoimmunity, and these are
usually represented by infections [10, 11]. A very recent work has experimentally identified a gut
bacterium that, when present in mice and humans, can migrate to other parts of the body, facilitat-
ing subsequent triggering of autoimmune disease in those organs [12]. Various mechanisms of onset
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of pathogen-induced autoimmune disease have been identified, including bystander activation [13]
and molecular mimicry [14, 15], which is particularly important in the context of autoimmunity
caused by viral infections.
A number of mathematical models have looked into dynamics of onset and development of au-
toimmune disease. Segel et al. [16] analysed interactions between effector and regulatory T cells
in the context of T cell vaccination, without explicitly specifying possible causes of autoimmunity.
Similar models were later studied by Borghans et al. [17, 18] who demonstrated possible onset
of autoimmune state, defined as stable above-threshold oscillations in the number of autoreactive
cells, as a result of interactions between regulatory and autoreactive T cells. Leo´n et al. [19, 20, 21]
and Carneiro et al. [22] have studied interactions between different T cells, with an emphasis on
the suppressing role of regulatory T cells in the dynamics of immune response and control of
autoimmunity. Alexander and Wahl [23] have also looked into the role of regulatory T cells, in
particular focusing on their interactions with professional APCs and effector cells for the purpose
of controlling immune response. Iwami et al. [24, 25] explicitly included a separate compartment
representing the viral population in their models of immune response, and showed that the func-
tional form of the growth function for susceptible host cells can have a significant effect on the
resulting immune dynamics. Despite being able to explain the emergence of autoimmunity as a by-
product of immune response to infection, these models were not able to exhibit another practically
important dynamical regime of normal viral clearance. For the case of pathogen-induced autoim-
munity arising through bystander activation, Burroughs et al. [26, 27, 28] have developed a model
that investigates interactions between T cells and interleukin-2 (IL-2), an important cytokine, in
mediating the onset of autoimmunity.
Among various parts of the immune system involved in coordinating an effective immune re-
sponse, a particularly significant role is known to be played by the T cells, with experimental
evidence suggesting that regulatory T cells are vitally important for controlling autoimmunity
[29, 30, 31, 32]. To account for this fact in mathematical models, Alexander and Wahl [23] and
Burroughs et al. [26, 27] have explicitly included a separate compartment for regulatory T cells that
are activated by autoantigens and suppress the activity of autoreactive T cells. Another framework
for modelling the effects of T cells on autoimmune dynamics is by using the idea that T cells have
different or tunable activation thresholds (TAT), which result in different immune functionality of
the same T cells, and also allow T cells to adjust their response to simulation by autoantigens. This
approach was proposed for the analysis of the peripheral and central T cell dynamics [33, 34, 35], it
has also been used to study differences in activation/response thresholds that are dependent on the
activation state of the T cell [36]. Murine and human experiments have confirmed that activation
of T cells can indeed change dynamically during their circulation [37, 38, 39, 40]. To model this
feature, van den Berg and Rand [41], and Scherer et al. [42] developed stochastic models for the
tuning of activation thresholds.
Blyuss and Nicholson [43, 44] have proposed a mathematical model of autoimmunity resulting
from immune response to a viral infection through a mechanism of molecular mimicry. This model
explicitly includes the virus population and two types of T cells with different activation thresholds,
and it also accounts for a biologically realistic scenario where infection and autoimmune response
can occur in different organs of the host. Besides the normal viral clearance and chronic infection,
in some parameter regime the model also exhibits an autoimmune state characterised by stable
oscillations in the amounts of cell populations. From a clinical perspective, such behaviour is to
be expected, as it is associated with relapses and remissions that have been observed in a number
of autoimmune diseases, such as autoimmune thyroid disease, MS, and uveitis [45, 46, 47]. One
deficiency of this model is the fact that the oscillations associated with autoimmune regime can only
occur if the amount of free virus and the number of infected cells are also exhibiting oscillations,
while in clinical and laboratory settings, autoimmunity usually occurs after the initial infection has
been fully cleared. To overcome this limitation, Fatehi et al. [48] have recently developed a more
advanced model that also includes regulatory T cells and cytokines, which has allowed the authors
to obtain a more realistic representation of immune response and various dynamical regimes. A
particularly important practical insight provided by this model is the observation that it is not only
the system parameters, but also the initial level of infection and the initial state of the immune
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system, that determine whether the host will just successfully clear the infection, or will proceed
to develop autoimmunity. Approaching the same problem from another perspective, Fatehi et al.
[49] have investigated the role of stochasticity in driving the dynamics of immune response and
determining which of the immune states is more likely to be attained. The authors have also
determined an experimentally important characterisation of autoimmune state, as provided by the
dependence of variance in cell populations on various system parameters.
In this paper, we develop and analyse a model of autoimmune dynamics, with particular focus on
the role of time delays associated with different aspects of immune response, as well as an inhibiting
effect of regulatory T cells on secretion of IL-2. In the next section, we introduce the model and
discuss its basic properties. Section 3 contains systematic analysis of all steady states, including
conditions for their feasibility and stability. Section 4 contains a bifurcation analysis of the model
and demonstrates various types of behaviour that the system exhibits depending on parameters
and initial conditions, which includes identification of attraction basins of various states. The paper
concludes in Section 5 with the discussion of results.
2 Model Derivation
To understand how interactions between different parts of the immune system and the cytokine
can lead to autoimmunity, we consider a model illustrated in a diagram shown in Figure 1. In
this model, unlike earlier work of Blyuss and Nicholson [43, 44], we consider a situation where a
viral infection and possible autoimmunity occur in the same organ of the host. The healthy host
cells, whose number is denoted by A(t), in the absence of infection are assumed to grow logistically
with linear growth rate r and carrying capacity N , and they acquire infection at rate β from the
infected cells F (t). Since experimental evidence suggests that antibodies play a secondary role
compared to T cells [50], and autoimmunity can develop even in the absence of B cells [51], we do
not include antibody response in the model, but focus solely on the dynamics of T cell populations.
Na¨ıve (inactivated) T cells Tin(t) are assumed to be in homeostasis [43, 24, 25], and once they are
activated through interaction with infected cells, which occurs at rate α, a proportion p1 of them will
go on to differentiate into additional regulatory T cells, a fraction p2 will become normal activated
T cells Tnor(t) able to destroy infected cells at rate µF upon recognition of foreign antigen present
on their surface. The remaining proportion of (1 − p1 − p2) of T cells will become autoreactive
T cells Taut(t) that, in light of their lower activation threshold will be eliminating both infected
cells and healthy host cells at rate µa due to the above-mentioned cross-reactivity between some
epitopes in self- and foreign antigens. Regulatory T cells Treg(t) are assumed to be in their own
homeostasis [52], and their main contribution to immune dynamics lies in suppressing autoreactive
T cells at rate δ1. To reduce the dimensionality of the model, it is assumed that the process of
viral production is occurring very fast compared to other characteristic timescales of the model,
thus the viral population can be represented by its quasi-steady-state approximation, i.e., it is
taken to be proportional to the number of infected cells, and this eliminates the need for a separate
compartment for free virus.
A number of different cytokines mediate immune response to infection, and in the context of
T cell dynamics, a particular important role is played by interleukin 2 (IL-2), represented by the
variable I(t) in the model, which acts to enhance the proliferation of T cells, which, in turn, secrete
further IL-2. One of the actions of regulatory T cells is to suppress the expression of IL-2 [53],
which is only produced by the activated T cells, but not by the regulatory T cells [54, 55]. To
represent this mathematically, we will assume that Tnor and Taut produce IL-2 at rates σ1 and
σ2, and conversely, IL-2 enhances proliferation of Treg, Tnor and Taut at rates ρ1, ρ2, and ρ3. We
include in the model suppression of IL-2 by regulatory T cells at rate δ2, in a manner similar to
Burroughs et al. [28].
While the production of new virus particles by infected cells is assumed to be fast, we explicitly
include in the model time delay τ1 associated with the actual process of infection, which includes
multiple stages of the eclipse phase of viral life cycle, such as virus attachment, cell penetration and
uncoating [56, 57]. We also include the time delay τ2 associated with simulation and proliferation
3
Figure 1: A schematic diagram of immune response to infection. Blue indicates host cells (susceptible and
infected), red denotes different T cells (na¨ıve, regulatory, normal activated, and autoreactive T cells), yellow
shows cytokines (interleukin 2). τi inside each of the subnetworks shows the time delay associated with that
process.
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of T cells by IL-2, and the time delay τ3 between antigen encounter and resulting T cell expansion
[58].
With the above assumptions, the complete model takes the form
dA
dt
= rA
(
1− A
N
)
− βAF − µaTautA,
dF
dt
= βA (t− τ1)F (t− τ1)− dFF − µFTnorF − µaTautF,
dTin
dt
= λin − dinTin − αTinF,
dTreg
dt
= λr − drTreg + p1αTin (t− τ3)F (t− τ3) + ρ1I (t− τ2)Treg (t− τ2) ,
dTnor
dt
= p2αTin (t− τ3)F (t− τ3)− dnTnor + ρ2I (t− τ2)Tnor (t− τ2) ,
dTaut
dt
= (1− p1 − p2)αTin (t− τ3)F (t− τ3)− daTaut − δ1TregTaut + ρ3I (t− τ2)Taut (t− τ2) ,
dI
dt
= σ1Tnor + σ2Taut − δ2TregI − diI.
Introducing non-dimensional variables
tˆ = rt, A = NAˆ, F = NFˆ , Tin =
λin
din
Tˆin, Treg =
λin
din
Tˆreg,
Tnor =
λin
din
Tˆnor, Taut =
λin
din
Tˆaut, I =
λin
din
Iˆ ,
where
βˆ =
βN
r
, µˆa =
µaλin
rdin
, dˆF =
dF
r
, µˆF =
µFλin
rdin
, dˆin =
din
r
, αˆ =
αN
r
,
λˆr =
λrdin
λinr
, dˆr =
dr
r
, dˆn =
dn
r
, dˆa =
da
r
, ρˆi =
ρiλin
rdin
, i = 1, 2, 3,
δˆ1 =
δ1λin
rdin
, δˆ2 =
δ2λin
rdin
, σˆ1 =
σ1
r
, σˆ2 =
σ2
r
, dˆi =
di
r
,
yields a rescaled model
dA
dt
= A (1−A)− βAF − µaTautA,
dF
dT
= βA (T − τ1)F (T − τ1)− dFF − µFTnorF − µaTautF,
dTin
dT
= din (1− Tin)− αTinF,
dTreg
dT
= λr − drTreg + p1αTin (T − τ3)F (T − τ3) + ρ1I (T − τ2)Treg (T − τ2) ,
dTnor
dT
= p2αTin (T − τ3)F (T − τ3)− dnTnor + ρ2I (T − τ2)Tnor (T − τ2) ,
dTaut
dT
= (1− p1 − p2)αTin (T − τ3)F (T − τ3)− daTaut − δ1TregTaut + ρ3I (T − τ2)Taut (T − τ2) ,
dI
dT
= σ1Tnor + σ2Taut − δ2TregI − diI,
(1)
where all hats in variables and parameters have been dropped for simplicity of notation, and all
parameters are assumed to be positive. It is easy to show that this system is well-posed, i.e.,
solutions with non-negative initial conditions remain non-negative for all t ≥ 0.
As a first step in the analysis of model (1), we look at its steady states
S∗ =
(
A∗, F ∗, T ∗in, T
∗
reg, T
∗
nor, T
∗
aut, I
∗) ,
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that can be found by equating to zero the right-hand sides of Equation (1) and solving the resulting
system of algebraic equations, deferring the discussion of conditionally stable steady states to
Section 3. First, we consider a situation where there are no infected cells at a steady state, i.e.,
F ∗ = 0, which immediately implies T ∗in = 1. In this case, there are four possible combinations of
steady states depending on whether T ∗nor and T
∗
aut are each equal to zero or positive. If T
∗
nor =
T ∗aut = 0, there are two steady states
S∗1 =
(
0, 0, 1,
λr
dr
, 0, 0, 0
)
, S∗2 =
(
1, 0, 1,
λr
dr
, 0, 0, 0
)
,
of which S∗1 is always unstable, and S
∗
2 is a disease-free conditionally stable steady state.
For T ∗nor 6= 0 and T ∗aut = 0, we again have two steady states
S∗3 =
(
0, 0, 1,
λrρ2
ρ2dr − ρ1dn , T
∗
nor, 0,
dn
ρ2
)
, S∗4 =
(
1, 0, 1,
λrρ2
ρ2dr − ρ1dn , T
∗
nor, 0,
dn
ρ2
)
,
where T ∗nor =
dn (λrδ2ρ2 + didrρ2 − didnρ1)
ρ2σ1(ρ2dr − ρ1dn) , but they are both unstable for any values of pa-rameters. In the case when T ∗nor = 0 and T ∗aut 6= 0, we have two further steady states S∗5 and
S∗6 ,
S∗5 =
(
0, 0, 1, T ∗reg, 0,
(
di + δ2T
∗
reg
) (
da + δ1T
∗
reg
)
ρ3σ2
,
da + δ1T
∗
reg
ρ3
)
,
S∗6 =
(
A∗, 0, 1, T ∗reg, 0,
(
di + δ2T
∗
reg
) (
da + δ1T
∗
reg
)
ρ3σ2
,
da + δ1T
∗
reg
ρ3
)
,
where A∗ = 1− µa
(
di + δ2T
∗
reg
) (
da + δ1T
∗
reg
)
ρ3σ2
, and
T ∗reg =
drρ3 − ρ1da ±
√
(drρ3 − ρ1da)2 − 4ρ1δ1λrρ3
2ρ1δ
.
The steady state S∗5 has A
∗ = 0, which implies the death of host cells, whereas the steady state
S∗6 corresponds to an autoimmune regime. The steady state S
∗
7 with T
∗
nor 6= 0 and T ∗aut 6= 0 exists
only for a particular combination of parameters, namely, when
δ1ρ
2
2λr = (ρ3dn − ρ2da)(ρ2dr − ρ1dn),
and is always unstable. Finally, when F ∗ 6= 0, the system (1) can have a steady state S∗8 with all
of its components being positive, but it does not appear possible to find a closed form expression
for this state.
In summary, besides the unconditionally unstable steady states, the model (1) has at most for
conditionally stable steady states: the disease-free steady state S∗2 , the steady state with the death
of host cells S∗5 , the autoimmune steady state S
∗
6 , and the persistent or chronic steady state S
∗
8 .
3 Stability Analysis of the Steady States
3.1 Stability Analysis of the Disease-Free Steady State
Linearising the system (1) near the disease-free steady state S∗2 yields the following equation for
characteristic roots λ
λ+ dF − βe−λτ1 = 0. (2)
If dF < β, the above equation always has a real positive root for any value τ1 ≥ 0, implying that
the disease-free steady state is always unstable for any value of the time delays. If, however, the
6
condition dF > β holds, the disease-free steady state is stable for τ1 = 0. To find out whether it
can lose stability for τ1 > 0, we look for solutions of Equation (2) in the form λ = iω. Separating
real and imaginary parts yields
dF = β cos(ωτ1),
ω = −β sin(ωτ1).
Squaring and adding these two equations gives the following equation for potential Hopf fre-
quency ω
ω2 + d2F − β2 = 0.
since dF > β, this equation does not have real roots for ω, suggesting that there can be no roots
of the form λ = iω of the characteristic Equation (2). This implies that in the case dF > β the
disease-free steady state S∗2 is stable for all values of the time delay τ1 ≥ 0.
3.2 Stability Analysis of the Death, Autoimmune and Chronic Steady
States
The steady state S∗5 (respectively, S
∗
6 ) is stable if
P <
da + δ1T
∗
reg
ρ3
<
dn
ρ2
, (3)
and all roots of the following equation have negative real part
∆(τ2, λ) = p2(λ)e
−2λτ2 + p1(λ)e−λτ2 + p0(λ) = 0, (4)
where
p2(λ) =
ρ1
(
da + δ1T
∗
reg
)2
ρ3
(
λ+ 2di + δ2T
∗
reg
)
,
p1(λ) =−
(
da + δ1T
∗
reg
)
ρ3
{
(ρ1 + ρ3)λ
2 +
[
ρ1
(
di + da + δ1T
∗
reg
)
+ ρ3
(
dr + 2di + 2δ2T
∗
reg
)]
λ
+ di(ρ1da + 2drρ3) + δ2T
∗
reg
(−ρ1δ1T ∗reg + 2drρ3)},
p0(λ) = (λ+ dr)
(
λ+ di + δ2T
∗
reg
) (
λ+ da + δ1T
∗
reg
)
,
and
P =

σ2
µa
(
di + δ2T ∗reg
) , for S∗5 ,
σ2 (β − dF )
µa (1 + β)
(
di + δ2T ∗reg
) , for S∗6 .
This steady state undergoes a steady-state bifurcation if
da + δ1T
∗
reg
ρ3
= P, or
da + δ1T
∗
reg
ρ3
=
dn
ρ2
, or δ1ρ1
(
T ∗reg
)2
= λrρ3. (5)
For τ2 = 0 these steady states are stable if T
∗
reg satisfies (3) and
δ1ρ1
(
T ∗reg
)2
> λrρ3,
a5
(
T ∗reg
)5
+ a4
(
T ∗reg
)4
+ a3
(
T ∗reg
)3
+ a2
(
T ∗reg
)2
+ a1T
∗
reg + a0 > 0,
(6)
where
a5 = −δ1δ2(δ1ρ1 − δ2ρ1 + δ2ρ3), a4 = daδ2(δ2ρ2 − δ1ρ1 − δ2ρ3)− diδ1(δ1ρ1 − δ2ρ1 + 2δ2ρ3),
a3 = −diδ1(daρ1 + diρ3) + dadiδ2(ρ1 − 2ρ3) + λrδ2(δ1ρ1 + δ2ρ3),
a2 = −dad2i ρ3 + λrδ2(daρ1 + 2diρ3), a1 = λrρ3(d2i + δ2λr), a0 = diρ3λ2r.
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To investigate whether stability can be lost for τ2 > 0, we use an iterative procedure described in
[59, 60] to determine a function F (ω), whose roots give the Hopf frequency associated with purely
imaginary roots of Equation (4). Substituting λ = iω into Equation (4), we define ∆(1)(τ2, λ) as
∆(1)(τ2, λ) = p0(iω)∆(τ2, iω)− p2(iω)e−2iωτ2∆(τ2, iω) = p(1)0 (iω) + p(1)1 (iω)e−iωτ2 ,
where
p
(1)
0 (iω) =|p0(iω)|2 − |p2(iω)|2,
p
(1)
1 (iω) =p0(iω)p1(iω)− p1(iω)p2(iω),
and the bar denotes the complex conjugate. If we define
F (ω) =
∣∣∣p(1)0 (iω)∣∣∣2 − ∣∣∣p(1)1 (iω)∣∣∣2 ,
then ∆(τ2, iω) = 0 whenever ω is a root of F (ω) = 0. The function F (ω) has the explicit form
F (ω) = ω12 + b10ω
10 + b8ω
8 + b6ω
6 + b4ω
4 + b2ω
2 + b0,
with
b0 =
(
δ1da + T
∗
reg
)4
ρ34
(
di + δ2T
∗
reg
) (
2T ∗regδ1ρ1 + daρ1 − drρ3
)
[ (
di + δ2T
∗
reg
)
(daρ1 + 3drρ3) + 2diρ1
(
da + δ1T
∗
reg
) ]
[
ρ1
(
da + δ1T
∗
reg
) (
2di + δ2T
∗
reg
)− drρ3 (di + δ2T ∗reg) ]2.
The explicit formulae for other coefficients of F (ω) can be found in Appendix 5. Introducing
s = ω2, the equation F (ω) = 0 can be equivalently rewritten as follows,
h(s) = s6 + b10s
5 + b8s
4 + b6s
3 + b4s
2 + b2s+ b0 = 0. (7)
Without loss of generality, suppose that Equation (7) has six distinct positive roots denoted by
s1, s2, ... , s6, which means that the equation F (ω) = 0 has six positive roots
ωi =
√
si, i = 1, 2, ..., 6.
Substituting λk = iωk into Equation (4) gives
τk,j =
1
ωk
[
arctan
(
ωk
(
(ρ1 + ρ3)ω
4
k + f2ω
2
k + f0
)(
ρ3Z − drρ1 − ρ23I∗ − ρ1δ2T ∗reg
)
ω4k + g2ω
2
k + g0
)
+ jpi
]
,
for k = 1, 2, ..., 6, j = 0, 1, 2, ..., where
f0 =− ρ12ρ32I∗3Z − ρ1ρ3 (2ρ1 + 3ρ3) I∗2Z2 + ρ1ρ3T ∗reg (−δ1ρ1 + 3δ2ρ1 + δ2ρ3) I∗2Z
− T ∗reg2δ22ρ12ρ3I∗2 − T ∗regδ1ρ1ρ3I∗Z2 + drρ3
(−δ1ρ1T ∗reg + drρ3) I∗Z
+ dr
(−T ∗regδ1ρ1 + 2drρ3)Z2,
f2 =− ρ12ρ3I∗2 + ρ32I∗Z + (ρ1 + 2ρ3)Z2 + ρ1T ∗reg (δ1 − δ2)Z − dr
(
T ∗regδ2ρ1 − drρ3
)
,
g0 = ρ1
2ρ3
2I∗3
(
2Z2 − 3T ∗regδ2Z + T ∗reg2δ22
)
+ ρ1ρ3
(−2T ∗regδ1ρ1 + 3drρ3) I∗2Z2
+ ρ1ρ3δ2T
∗
reg
(
T ∗regδ1ρ1 − drρ3
)
I∗2Z + drρ3
(
T ∗regδ1ρ1 − 2drρ3
)
I∗Z2,
g2 = ρ3I
∗
(
ρ1
2ρ3I
∗2 − ρ12I∗Z − 2ρ3Z2 − T ∗regδ1ρ1Z − dr2ρ3
)
− ρ1
(
dr + δ1T
∗
reg
)
Z2
+ dr
(−T ∗regδ1ρ1 + T ∗regδ2ρ1 + drρ3)Z,
8
and
I∗ =
da + δ1T
∗
reg
ρ3
, Z = di + δ2T
∗
reg.
This allows us to find
τ∗ = τk0,0 = min
1≤k≤6
{τk,0}, ω0 = ωk0 ,
as the first time delay for which the roots of the characteristic Equation (4) cross the imaginary
axis. To determine whether these steady states actually undergo a Hopf bifurcation at τ2 = τ
∗, we
have to compute the sign of dRe[λ(τ∗)]/dτ2. For τ = τ∗, λ(τ∗) = iω0, and we also define s0 = ω20 .
Lemma 3.1. Suppose h′(s0) 6= 0 and p(1)0 (iω0) 6= 0. Then the following transversality condition
holds
sgn
{
dRe(λ)
d τ2
∣∣∣∣
τ2=τ∗
}
= sgn[p
(1)
0 (iω0)h
′(s0)].
Proof. Considering pj(iω0) = xj(ω0) + iyj(ω0) for j = 0, 1, 2, we have
p
(1)
0 (iω0) =x
2
0 + y
2
0 − x22 − y22 ,
p
(1)
1 (iω0) =(x0x1 + y0y1 − x1x2 − y1y2) + (x0y1 + x2y1 − x1y0 − x1y2)i,
where all xj and yj are expressed in terms of system parameters and steady state values of the
variables. Substituting these expressions into ∆(τ2, iω0) = 0 and ∆
(1)(τ2, iω0) = 0, and then
separating real and imaginary parts gives
x2 cos(2ω0τ
∗) + y2 sin(2ω0τ∗) + x1 cos(ω0τ∗) + y1 sin(ω0τ∗) = −x0,
y2 cos(2ω0τ
∗)− x2 sin(2ω0τ∗) + y1 cos(ω0τ∗)− x1 sin(ω0τ∗) = −y0,
(x0x1 + y0y1 − x1x2 − y1y2) cos(ω0τ∗) + (x0y1 + x2y1 − x1y0 − x1y2) sin(ω0τ∗)
= −x20 − y20 + x22 + y22 ,
(x0y1 + x2y1 − x1y0 − x1y2) cos(ω0τ∗)− (x0x1 + y0y1 − x1x2 − y1y2) sin(ω0τ∗) = 0.
Solving this system of equations provides the values of sin(ω0τ
∗), cos(ω0τ∗), sin(2ω0τ∗), and cos(2ω0τ∗).
Taking the derivative of Equation (4) with respect to τ2, one finds(
d λ
d τ2
)−1
=
p′2(λ)e
−2λτ2 + p′1(λ)e
−λτ2 + p′0(λ)
λ (2p2(λ)e−2λτ2 + p1(λ)e−λτ2)
− τ2
λ
.
Hence,(
dRe(λ)
d τ2
∣∣∣∣
τ2=τ∗
)−1
= Re
{
p′2(λ)e
−2λτ2 + p′1(λ)e
−λτ2 + p′0(λ)
λ (2p2(λ)e−2λτ2 + p1(λ)e−λτ2)
}
τ2=τ∗
− Re
{τ2
λ
}
τ2=τ∗
= Re
{
p′2(iω0)e
−2iω0τ2 + p′1(iω0)e
−iω0τ2 + p′0(iω0)
iω0 (2p2(iω0)e−2iω0τ2 + p1(iω0)e−iω0τ2)
}
=
1
ω0
Im
{
p′2(iω0)e
−2iω0τ2 + p′1(iω0)e
−iω0τ2 + p′0(iω0)
2p2(iω0)e−2iω0τ2 + p1(iω0)e−iω0τ2
}
=
1
Λω0
[
− x2x′2 − y2y′2 + x0x′0 + y0y′0 + (x2y′1 − y2x′1 + x0y′1 − x′1y0) sin(ω0τ∗)
+ (x0x
′
1 + y0y
′
1 − x′1x2 − y′1y2) cos(ω0τ∗) + (x2y′0 − x′0y2 + x0y′2 − x′2y0) sin(2ω0τ∗)
+ (x0x
′
2 + y0y
′
2 − x′0x2 − y′0y2) cos(2ω0τ∗)
]
,
where
Λ =
∣∣2p2(iω0)e−2iω0τ2 + p1(iω0)e−iω0τ2∣∣2 .
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Figure 2: Regions of feasibility and stability of the steady states S∗5 and S
∗
6 with parameter values from Table
1 (a), and with µa = 10 (b). Black and red curves indicate the boundaries of feasibility and the steady-state
bifurcation, whereas dashed lines (blue/brown) show the boundaries of Hopf bifurcation of the steady states
S∗5 and S
∗
6 , respectively, with ‘fH’ indicating the fold-Hopf bifurcation. The first digit of the index refers to S
∗
5 ,
while the second corresponds to S∗6 , and they indicate that in that parameter region the respective steady state
is unfeasible (index is ‘0’), stable (index is ‘1’), unstable via Hopf bifurcation with a periodic solution around
this steady state (index is ‘2’), or unstable via a steady-state bifurcation (index is ‘3’). In all plots, the condition
β < dF holds, so the disease-free steady state S
∗
2 is also stable.
Substituting the values of sin(ω0τ
∗), cos(ω0τ∗), sin(2ω0τ∗), and cos(2ω0τ∗) found earlier gives(
dRe(λ)
d τ2
∣∣∣∣
τ2=τ∗
)−1
=
1
Λω0
F ′(ω0)
2 p
(1)
0 (iω0)
=
h′(s0)
Λ p
(1)
0 (iω0)
.
Therefore
sgn
{
dRe(λ)
d τ2
∣∣∣∣
τ2=τ∗
}
= sgn

(
dRe(λ)
d τ2
∣∣∣∣
τ2=τ∗
)−1 = sgn
{
h′(s0)
Λ p
(1)
0 (iω0)
}
= sgn[p
(1)
0 (iω0)h
′(s0)],
which completes the proof.
We can now formulate the main result concerning stability of the steady states S∗5 and S
∗
6 .
Theorem 3.2. Suppose the value of T ∗reg satisfies conditions (3) and (6). If Equation (7) has
at least one positive root s0, and p
(1)
0 (iω0)h
′(s0) > 0 with ω0 =
√
s0, then the steady state S
∗
5
(respectively, S∗6) is stable for 0 ≤ τ2 < τ∗, unstable for τ2 > τ∗, and undergoes a Hopf bifurcation
at τ2 = τ
∗.
Since T ∗reg satisfies conditions (3) and (6), the steady state S
∗
5/S
∗
6 is stable for τ2 = 0. Lemma
3.1 then ensures that τ∗ is the first positive value of the time delay τ2, for which the roots of the
characteristic Equation (4) cross the imaginary axis with positive speed. Hence, the steady state
S∗5/S
∗
6 is stable for 0 ≤ τ2 < τ∗, unstable for τ2 > τ∗, and undergoes a Hopf bifurcation at τ2 = τ∗.
Remark. A similar result can be formulated for a subcritical Hopf bifurcation of the steady state
S∗5/S
∗
6 at some higher value of τ2.
10
Table 1: Table of parameter values.
Parameter Value Parameter Value
β 1 ρ3 2
µa 20 dn 1
dF 1.1 da 0.001
µF 6 δ1 0.0025
din 1 δ2 0.001
α 0.4 σ1 0.15
λr 3 σ2 0.33
dr 0.4 di 0.6
p1 0.4 τ1 1.4
p2 0.4 τ2 0.6
ρ1 10 τ3 0.6
ρ2 0.8
The only remaining steady state is the persistent (chronic) equilibrium S∗8 with all of its com-
ponents being positive. Since it did not prove possible to find a closed form expression for this
steady state, its stability also has to be studied numerically.
4 Numerical Stability Analysis and Simulations
To investigate the role of different parameters in the dynamics of model (1), in this section we per-
form a detailed numerical bifurcation analysis and simulations of this model. Stability of different
steady states is determined numerically by computing the largest real part of the characteristic
eigenvalues, which is achieved by using a pseudospectral method implemented in a traceDDE suite
in MATLAB [61].
Analytical results from the previous section suggest that at β = dF , the disease-free steady state
S∗2 undergoes a transcritical bifurcation. For β < dF , the disease-free steady state S
∗
2 is stable, and
the chronic steady state is infeasible. On the contrary, when β > dF , the disease-free steady state
S∗2 is unstable, and in this case it makes sense to investigate stability of the chronic steady state.
Therefore, these two cases are considered separately, and as a first step we fix the baseline values
as given in Table 1. For this choice of parameters, we have dF − β > 0, implying that S∗2 is always
stable, and Figure 2 illustrates how the stability of S∗5 and S
∗
6 is affected by parameters. This figure
indicates that the steady states S∗5 and S
∗
6 are only biologically feasible if the regulatory T cells do
not grow too rapidly and do not clear autoreactive T cells too quickly. Importantly, Figure 2 shows
that the value of the rate δ2 of clearance of IL-2 by regulatory T cells does not have any effect on
the thresholds of λr and δ1, where the steady states S
∗
5 and S
∗
6 lose their feasibility. Moreover,
if λr and δ1 are small, then increasing the rate δ2 at which Tregs inhibit the production of IL-2
makes S∗6 become unfeasible, resulting in a stable steady state S
∗
5 , which has the zero population
of host cells A. On the other hand, the steady state S∗6 associated with autoimmune responses is
favoured for higher values of δ1 and λr. In the case stable periodic solutions around these steady
states, increasing δ2 results in the disappearance of oscillations and stabilisation of the associated
steady state. At the intersection of the lines of Hopf bifurcation and the steady-state bifurcation,
as determined by Theorem 3.2 and conditions (5), one has the co-dimension two fold-Hopf (also
known as zero-Hopf or saddle-node Hopf) bifurcation [62].
Since our earlier analysis showed that stability of the steady states S∗5/S
∗
6 is affected by the time
delay τ2, in Figure 3 we consider stability of these equilibria depending on τ2 and the rate δ2. For
the steady state S∗5 , if the effect of IL-2 on promoting proliferation of T cells is fast (i.e., τ2 is small),
there is a large range of δ2, starting with some very low values, for which S
∗
5 is stable. Increasing
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Figure 3: Stability of the steady states S∗5 (a), and S
∗
6 (b) with parameter values from Table 1. White area
shows the region where the steady state S∗6 is infeasible. Colour code denotes max[Re(λ)] for the steady states
when they are feasible. In all plots the condition dF > β holds, so the disease-free steady state S
∗
2 is stable.
Basins of attraction of different steady states depending on the initial conditions (c), with other initial conditions
specified in (8), and parameter values from Table 1, except for τ2 = 18. Cyan and pink areas are the basins of
attraction of S∗2 and S
∗
6 , respectively.
the time delay τ2 results in the Hopf bifurcation of this steady state as described in Theorem 3.2.
One should note that for intermediate values of δ2, the steady state S
∗
5 undergoes stability switches,
whereby increasing the delay τ2 further results in a subcritical Hopf bifurcation, which stabilises
S∗5 , but after some number of such stability switches eventually the steady state S
∗
5 is unstable.
For higher still values of δ2, the steady state S
∗
5 remains stable for an entire range of τ2 values,
and the only way to lose its stability is via a steady state bifurcation as given by (5). In the case
of autoimmune steady state S∗6 , the situation is somewhat different in that increasing δ2 beyond
some critical values makes this steady state biologically infeasible. At the same time, for an entire
range of δ2 values where it is feasible, this steady state exhibits a single loss of stability through a
Hopf bifurcation for some critical value of the time delay τ2, in agreement with Theorem 3.2.
As mentioned earlier, for parameter values used in Figure 3, the disease-free steady state S∗2 is
stable. Hence, the system exhibits a bi-stability between a disease-free state and either stable steady
states S∗5/S
∗
6 , or periodic solutions around these steady states. To investigate this bi-stability, we
choose parameter values as in Table 1 except for τ2 = 18, which corresponds to a stable steady
state S∗6 , and we fix initial conditions for state variables as follows,
(A(0), Tin(0), Tnor(0), Taut(0), I(0)) = (0.9, 0.8, 0, 0, 0), (8)
except for initial amounts of infected cells and regulatory T cells that are allowed to vary. Figure 3c
illustrates the bi-stability between S∗2 and S
∗
6 in terms of their basins of attraction. It is worth noting
that recently significant research in approximation theory and meshless interpolation has focused
on developing techniques for detection and analysis of attraction basins [63, 64, 65, 66, 67, 68].
Figure 3c suggests that for very large initial amounts of regulatory T cells, the system converges to
the disease-free steady state. It also indicates that if the initial amount of infected cells is very small
or is bigger than some specific value, then the infection will be cleared. Interestingly, increasing
the initial amount of the regulatory T cells results in a larger range of initial amounts of infection,
for which the system tends to a stable autoimmune state S∗6 . In Figure 3b we discovered that
increasing τ2 makes the autoimmune steady state S
∗
6 undergo a Hopf bifurcation, in which case
the system will exhibit a bi-stability between stable S∗2 and a periodic solution around S
∗
6 . Our
numerical investigation suggests that the shape of basins of attraction in this case is qualitatively
similar to that shown in Figure 3c, with the basin of attraction of the stable steady state S∗6 being
replaced by the basin of attraction of the periodic solution around this steady state.
Figure 4 shows temporary evolution of the system (1) in the regime of bi-stability between a
stable disease-free steady state and a stable autoimmune steady state S∗6 (similar pattern of be-
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Figure 4: Numerical solutions of the model with parameters values from Table 1, except for τ2 = 18. (a,b) Sta-
ble disease-free steady state S∗2 for F (0) = 0.18, and Treg(0) = 100. (c,d) Transient oscillations settling on a
stable steady state S∗6 for F (0) = 0.18, and Treg(0) = 10. (e,f) Autoimmune dynamics represented by periodic
oscillations around the steady state S∗6 for τ2 = 32, F (0) = 0.18, and Treg(0) = 10.
haviour is exhibited in the case of bi-stability between S∗2 and S
∗
5 ). It also illustrates how the
system develops a periodic solution around the steady state S∗6 for a higher value of τ2. Periodic
oscillations around the steady state S∗6 biologically correspond to a genuine autoimmune state:
after the initial infection is cleared, the system exhibits sustained endogenous oscillations, charac-
terised by periods of significant reduction in the number of organ cells through a negative action of
autoreactive T cells, separated by periods of quiescence. This type of behaviour is often observed in
clinical manifestations of autoimmune disease [44, 45, 46, 47]. This result has substantial biological
significance as effectively it suggests that even for the same kinetic parameters of immune response,
the ultimate state of the system, which can be either a successful clearance of infection without
lasting consequences, or progression to autoimmunity, also depends on the strength of the initial
infection and of the initial state of the immune system, as represented by the initial number of
regulatory T cells.
Next we consider a situation where β > dF , so the disease-free steady state is unstable, and the
system can have three steady states S∗5 , S
∗
6 and S
∗
8 . Our earlier results [48] suggest that in the case
where regulatory T cells do not inhibit the production of IL-2, i.e., for δ2 = 0, the steady state
S∗6 is stable. Figure 5 shows regions of feasibility and stability of these steady states depending on
δ2 and τ2 in this case. One observes that S
∗
5 and S
∗
6 , whose stability boundaries are determined
by Theorem 3.2, exhibit the same behaviour as in Figure 3, namely, for S∗5 increasing τ2 causes
multiple stability switches for smaller values of δ2, and the steady state is unstable for very small
δ2 and stable for large δ2; in contrast, S
∗
5 exhibits a single loss of stability via Hopf bifurcation at
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Figure 5: Stability of S∗5 (a), S
∗
6 (b), and S
∗
8 (c), with parameter values from Table 1, except for β = 1.4 and
σ2 = 1, so that β > dF . White area shows the region where the steady state is infeasible. Colour code denotes
max[Re(λ)] for each steady states when it is feasible. (d) Summary of stability results. Green indicates the
region where S∗6 and S
∗
8 are stable, and S
∗
5 is unstable, whereas red is the area where S
∗
5 and S
∗
8 are stable, and
S∗6 is infeasible. Yellow is where S
∗
8 is stable, S
∗
5 is unstable, and S
∗
6 is infeasible. Purple shows the region where
S∗6 is stable, but S
∗
5 and S
∗
8 are unstable. Blue and cyan indicate the regions where S
∗
5 and S
∗
6 are unstable,
but S∗8 is stable or unstable, respectively.
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Figure 6: Bi-stability analysis of the steady states S∗5 , S
∗
6 , and S
∗
8 with the same parameter values as in
Figure 5, except for (a) δ2 = 0.1, (b) δ2 = 0.02. Yellow indicates the basin of attraction of the chronic steady
state S∗8 , purple is the basin of attraction of periodic solutions around S
∗
8 . Red and pink are the basins of
attraction of the steady states S∗5 and S
∗
6 , respectively.
some critical value of the time delay τ2, which itself increases with δ2. Behaviour of S
∗
8 is similar
to that of S∗5 in that there are multiple stability switches for increasing value of τ2 and small to
intermediate values of δ2, while for high values of δ2, the chronic steady state S
∗
8 is stable for
all values of τ2. Figure 5d divides the δ2-τ2 plane into different regions based on feasibility and
stability of these steady states and shows that increasing δ2 makes the autoimmune steady state
S∗6 infeasible. In other regions, the system can exhibit a bi-stability between a stable steady state
S∗8 and either a stable steady state S
∗
5 , or a periodic solution around S
∗
5 .
Figure 6 illustrates the basins of attraction of the steady states S∗5 , S
∗
6 and S
∗
8 , as well as periodic
solutions around S∗8 . Figure 6a shows the basins of attraction of the steady states S
∗
5 and S
∗
8 and
demonstrates that if the initial number of regulatory T cells or infected cells is sufficiently high, or
the initial amount of infected cells is very low, the immune response neither eliminates infection
nor clears autoreactive T cells, and the system approaches the stable steady state S∗5 . Figure 6b
illustrates bi-stability between the stable steady state S∗6 and a periodic solution around S
∗
8 , and
has a different behaviour to than shown in Figure 6a. This figure suggests that for a specific range
of F (0) the system converges to a stable autoimmune state S∗6 for all values of Treg(0). However, if
the initial number of infected cells is very high or very low, the system instead develops a periodic
solution around the steady state S∗8 associated with chronic infection.
Figure 7 illustrates a regime of bi-stability between a stable steady state S∗6 and a periodic
solution around S∗8 for combinations of initial conditions indicated by crossed in Figure 6b. It also
illustrates how the system develops a stable solution around the steady state S∗8 for a higher value
of τ2. This figure shows that by increasing the initial number of infected cells the behaviour of
the system changes, as it then approaches the autoimmune steady state S∗6 . Interestingly, one can
observe that for high values of F (0) the system can eliminate the infection, but it cannot clear the
autoreactive T cells, in which case the system converges to S∗6 . On the other hand, for a smaller
number of infected cells the system develops a periodic solution around the endemic steady state.
Figure 8 shows how the stability of the chronic infection steady state S∗8 changes with respect
to time delays. Figure 8a indicates that for small values of τ2 (i.e., when the influence of IL-2 on
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Figure 7: Numerical solutions of the model with same parameters values as Figure 6b. (a,b) Stable steady state
S∗6 for F (0) = 0.002 and Treg(0) = 200. (c,d) Periodic oscillations around the steady state S
∗
8 for F (0) = 0.001
and Treg(0) = 200. (e,f) Transient oscillations settling on a stable steady state S
∗
8 for τ2 = 25, F (0) = 0.001
and Treg(0) = 200.
proliferation of T cells is occurring quite rapidly), the steady state S∗8 is stable, and increasing the
time delay τ1 associated with viral eclipse phase does not have an effect on its stability. At the same
time, if τ2 exceeds some specific value, by increasing τ1 the chronic steady state switches between
being stable or unstable. Figure 8b demonstrates a different behaviour, suggesting that for each
value of τ1, there is small range of τ3 values where S
∗
8 is stable, but for smaller and larger values
of τ3 it is unstable. For intermediate values of the eclipse phase delay τ1, there is an additional
narrow range of τ3 values where S
∗
8 is stable. Figure 8c illustrates that for very small, respectively
very large, values of τ3, the chronic infection steady state is stable, respectively unstable for any
value of τ2; for intermediate values of τ3, this steady state undergoes a finite number of stability
switches for increasing values of τ2 and eventually becomes unstable.
It should be noted Figure 8 shows that unlike τ1 and τ2, once the steady state S
∗
8 loses stability
via Hopf bifurcation due to increasing τ3, it cannot regain stability for higher values of τ3.
16
Figure 8: Colour code denotes max[Re(λ)] for the endemic steady state S∗8 depending on τ1 − τ2 (a), τ1 − τ3
(b), and τ3 − τ2 (c), with the parameter values taken from Table 1, except for β = 1.4, σ2 = 1, and δ2 = 0.04.
5 Conclusions
In this paper, we have developed and analysed a time-delayed model of immune response to a viral
infection, which accounts for T cells with different activation thresholds, a cytokine mediating T cell
proliferation, as well as regulatory T cells. Particular attention is payed to the dual suppressive role
of regulatory T cells in terms of reducing the amount of autoreactive T cells, and also inhibiting
IL-2. To achieve better biological realism of the model, we have explicitly included time delays
associated with the eclipse phase of the virus life cycle, stimulation/proliferation of T cells by IL-2,
and suppression of IL-2 by regulatory T cells. Depending on the values of parameters, the system
can have four steady states: the disease-free state, the state characterised by the death of host cells,
the autoimmune state, and a state of chronic infection. We have established conditions for stability
and steady-state or Hopf bifurcations of these steady states in terms of system parameters.
In the case where the natural death rate of infected cells exceeds the infection rate, the immune
system is able to clear the infection, and the disease-fee steady state is stable. In this regime, the
system can also support the autoimmune steady state or the steady state with the death of host
cells, either of which can be stable, or give rise to a periodic solution emerging via Hopf bifurcation.
In the opposite case, when the natural death rate of infected cells is smaller than the infection rate,
the disease-fee steady state is unstable, but it is possible to have a bi-stability between the other
three steady states or periodic solutions around them. To better understand bi-stability between
different dynamical regimes, we have used numerical simulations to identify basins of attraction
of different steady states and periodic solutions depending on the initial level of infection and the
initial number of regulatory T cells. The fact that for the same parameter values the system can
exhibit bi-stability between a disease-free steady state and an autoimmune state, represented by
sustained periodic oscillations following the clearance of infection, is very important from a clinical
point of view, as effectively it suggests that the progress and eventual outcome of viral infection
is also determined by the strength of infection and the initial state of the immune system. One
counter-intuitive observation is that in the case of bi-stability with a disease-free steady state, for
higher initial numbers of regulatory T cells, the autoimmune steady state is actually stable for a
wider range of initial levels of infection. In this regime of bi-stability, increasing the time delay
associated with the positive impact of IL-2 on proliferation of T cells results in the loss of stability of
autoimmune steady state and emergence of autoimmune dynamics, characterised by stable periodic
oscillations. On the contrary, in the case where the disease-free steady state is unstable, increasing
this time delay results in stabilisation of the chronic infection.
There are several directions in which the work presented in this paper can be extended. One di-
rection is exploration of the contributions from other components of immune response, more specif-
ically, antibodies and memory T cells, to the onset and progress of autoimmunity [69, 70]. This is
particularly important from the perspective that clinically the onset of autoimmune disease is often
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taking place on a much longer scale than the timescale of a regular immune response to a viral
infection, so memory T cells can be expected to play a more substantial role. While our model has
focused on one specific growth cytokine IL-2, a number of other cytokines, such as IL-7 [71], TNFβ
and IL-10 [29], are known to significantly affect homeostasis and proliferation of different types of
T cells, as well as mediate their efficiency in eliminating the infection. Including these immune
mediators explicitly in the model can provide further significant insights into the dynamics of im-
mune response, as has been recently demonstrated on the example of a detailed model of immune
response to hepatitis B [72]. Another biologically relevant and mathematically challenging problem
is the investigation of the interplay between stochasticity, which is known to be an intrinsic feature
of immune response [73, 49], and effects of time delays associated with various aspects of immune
dynamics.
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Coefficients of Equation (7) for Hopf frequency are given below.
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2−2 da2diδ23ρ1ρ3−7 da2drδ1δ22ρ12+
4 dadi
2δ1
2δ2ρ1
2+2 dadi
2δ1δ2
2ρ1
2−30 dadi2δ1δ22ρ1ρ3−15 dadidrδ12δ2ρ12−4 dadidrδ1δ22ρ12+20 dadidrδ23ρ32+
8 dadr
2δ1δ2
2ρ1ρ3+4 dadr
2δ2
3ρ3
2−4 di3δ12δ2ρ12−20 di3δ12δ2ρ1ρ3−2 di2drδ13ρ12−12 di2drδ12δ2ρ12−
7 di
2drδ1δ2
2ρ1
2+36 di
2drδ1δ2
2ρ3
2+6 didr
2δ1
2δ2ρ1ρ3+20 didr
2δ1δ2
2ρ1ρ3+12 didr
2δ1δ2
2ρ3
2−2 didr2δ23ρ1ρ3+
20 didr
2δ2
3ρ3
2+3 dr
3δ1δ2
2ρ3
2−4 dr3δ23ρ32
)
I∗4+
(
2 da
3di
2δ1δ2
2ρ1
2−4 da3didrδ23ρ1ρ3−4 da3dr2δ1δ22ρ12−
4 da
3dr
2δ2
3ρ1ρ3+2 da
2di
3δ1
2δ2ρ1
2−12 da2di2drδ1δ22ρ1ρ3−8 da2didr2δ12δ2ρ12−6 da2didr2δ1δ22ρ12−
36 da
2didr
2δ1δ2
2ρ1ρ3−4 da2didr2δ23ρ1ρ3−32 da2didr2δ23ρ32−2 da2dr3δ1δ22ρ1ρ3+4 da2dr3δ23ρ1ρ3−
4 dadi
3drδ1
2δ2ρ1ρ3−4 dadi2dr2δ13ρ12−12 dadi2dr2δ12δ2ρ12−36 dadi2dr2δ12δ2ρ1ρ3+2 dadi2dr2δ1δ22ρ12−
18
24 dadi
2dr
2δ1δ2
2ρ1ρ3−96 dadi2dr2δ1δ22ρ32−8 dadidr3δ12δ2ρ1ρ3+20 dadidr3δ1δ22ρ1ρ3−4 dadidr3δ23ρ1ρ3−
10 dadr
4δ1δ2
2ρ3
2−2 di3dr2δ13ρ12−4 di3dr2δ13ρ1ρ3−2 di3dr2δ12δ2ρ12−12 di3dr2δ12δ2ρ1ρ3−32 di3dr2δ12δ2ρ32−
2 di
2dr
3δ1
3ρ1ρ3 + 8 di
2dr
3δ1
2δ2ρ1ρ3 + 12 di
2dr
3δ1δ2
2ρ1ρ3− 10 didr4δ12δ2ρ32− 16 didr4δ23ρ32
)
I∗2 +
8 dr
2
(
da
4diδ2
3 + 6 da
3di
2δ1δ2
2 + da
3dr
2δ1δ2
2 + 6 di
3δ1
2δ2da
2 + 3 da
2didr
2δ1
2δ2 + da
2didr
2δ2
3 +
dadi
4δ1
3+dadi
2δ1
3dr
2+3 dadi
2δ1dr
2δ2
2+di
3δ1
2δ2dr
2
))
T ∗reg
3+
(
2 δ2
2ρ1
4ρ3
4I∗8−ρ12ρ32
(
da
2δ2
2ρ1
2+
6 dadiδ1δ2ρ1
2 + 18 dadiδ2
2ρ1ρ3 + 2 dadrδ2
2ρ1ρ3 + 4 di
2δ1
2ρ1
2 + 16 di
2δ1δ2ρ1
2 + 40 di
2δ1δ2ρ1ρ3 +
di
2δ2
2ρ1
2 + 20 di
2δ2
2ρ1ρ3 + 52 di
2δ2
2ρ3
2 + 4 didrδ1δ2ρ1ρ3 − 18 didrδ22ρ1ρ3 + 5 dr2δ22ρ32
)
I∗6 +
2 ρ1ρ3
(
2 da
3diδ2
2ρ1
2−da3drδ22ρ12+12 da2di2δ1δ2ρ12+da2di2δ22ρ12+3 da2di2δ22ρ1ρ3−5 da2didrδ1δ2ρ12−
2 da
2didrδ2
2ρ1
2+4 da
2dr
2δ2
2ρ1ρ3+4 dadi
3δ1
2ρ1
2+6 dadi
3δ1δ2ρ1
2−12 dadi3δ1δ2ρ1ρ3−8 dadi2drδ1δ2ρ12+
dadi
2drδ2
2ρ1
2+36 dadi
2drδ2
2ρ3
2+14 dadidr
2δ1δ2ρ1ρ3+12 dadidr
2δ2
2ρ3
2+3 dadr
3δ2
2ρ3
2−4 di4δ12ρ1ρ3−
4 di
3drδ1
2ρ1
2−7 di3drδ1δ2ρ12+28 di3drδ1δ2ρ32+3 di2dr2δ12ρ1ρ3+22 di2dr2δ1δ2ρ1ρ3+12 di2dr2δ1δ2ρ32+
3 di
2dr
2δ2
2ρ1ρ3+36 di
2dr
2δ2
2ρ3
2+9 didr
3δ1δ2ρ3
2−12 didr3δ22ρ32
)
I∗4+
(
−da4di2δ22ρ12−da4dr2δ22ρ12−
2 da
3di
3δ1δ2ρ1
2 − 12 da3di2drδ22ρ1ρ3 − 6 da3didr2δ1δ2ρ12 − 10 da3didr2δ22ρ1ρ3 − 2 da3dr3δ22ρ1ρ3 −
da
2di
4δ1
2ρ1
2−20 da2di3drδ1δ2ρ1ρ3−7 da2di2dr2δ12ρ12−6 da2di2dr2δ1δ2ρ12−30 da2di2dr2δ1δ2ρ1ρ3−
2 da
2di
2dr
2δ2
2ρ1
2−12 da2di2dr2δ22ρ1ρ3−48 da2di2dr2δ22ρ32−16 da2didr3δ1δ2ρ1ρ3+10 da2didr3δ22ρ1ρ3−
5 da
2dr
4δ2
2ρ3
2 − 4 dadi4drδ12ρ1ρ3 − 4 dadi3dr2δ12ρ12 − 10 dadi3dr2δ12ρ1ρ3 − 2 dadi3dr2δ1δ2ρ12 −
24 dadi
3dr
2δ1δ2ρ1ρ3−64 dadi3dr2δ1δ2ρ32−10 dadi2dr3δ12ρ1ρ3+16 dadi2dr3δ1δ2ρ1ρ3−12 dadi2dr3δ22ρ1ρ3−
20 dadidr
4δ1δ2ρ3
2−di4dr2δ12ρ12−4 di4dr2δ12ρ1ρ3−8 di4dr2δ12ρ32+2 di3dr3δ12ρ1ρ3+4 di3dr3δ1δ2ρ1ρ3−
5 di
2dr
4δ1
2ρ3
2−24 di2dr4δ22ρ32
)
I∗2+2 dr2
(
6 da
4di
2δ2
2+da
4dr
2δ2
2+16 da
3di
3δ1δ2+8 da
3didr
2δ1δ2+
6 da
2di
4δ1
2+6 da
2di
2dr
2δ1
2+6 da
2di
2dr
2δ2
2+8 dadi
3dr
2δ1δ2+di
4dr
2δ1
2
))
T ∗reg
2+
(
8 diδ2ρ1
4ρ3
4I∗8−
4 diρ1
2ρ3
2
(
da
2δ2ρ1
2+2 dadiδ1ρ1
2+6 dadiδ2ρ1ρ3+3 dadrδ2ρ1ρ3+2 di
2δ1ρ1
2+4 di
2δ1ρ1ρ3+di
2δ2ρ1
2+
8 di
2δ2ρ1ρ3 + 12 di
2δ2ρ3
2 + 2 didrδ1ρ1ρ3 − 6 didrδ2ρ1ρ3 + 3 dr2δ2ρ32
)
I∗6 + 2 diρ1ρ3
(
4 da
3diδ2ρ1
2 +
da
3drδ2ρ1
2 + 5 da
2di
2δ1ρ1
2 + 3 da
2di
2δ2ρ1
2 + 8 da
2di
2δ2ρ1ρ3 + 5 da
2didrδ1ρ1
2 − 4 da2didrδ2ρ12 +
8 da
2dr
2δ2ρ1ρ3+4 dadi
3δ1ρ1
2−2 dadi2drδ1ρ12+3 dadi2drδ2ρ12+28 dadi2drδ2ρ32+8 dadidr2δ1ρ1ρ3+
12 dadidr
2δ2ρ3
2 + 9 dadr
3δ2ρ3
2 − 2 di3drδ1ρ12 + 8 di3drδ1ρ32 + 8 di2dr2δ1ρ1ρ3 + 4 di2dr2δ1ρ32 +
8 di
2dr
2δ2ρ1ρ3+28 di
2dr
2δ2ρ3
2+6 didr
3δ1ρ3
2−12 didr3δ2ρ32
)
I∗4−2 di
(
da
4di
2δ2ρ1
2+da
4dr
2δ2ρ1
2+
da
3di
3δ1ρ1
2+6 da
3di
2drδ2ρ1ρ3+3 da
3didr
2δ1ρ1
2+4 da
3didr
2δ2ρ1ρ3+4 da
3dr
3δ2ρ1ρ3+4 da
2di
3drδ1ρ1ρ3+
da
2di
2dr
2δ1ρ1
2 + 4 da
2di
2dr
2δ1ρ1ρ3 + 2 da
2di
2dr
2δ2ρ1
2 + 6 da
2di
2dr
2δ2ρ1ρ3 + 16 da
2di
2dr
2δ2ρ3
2 +
7 da
2didr
3δ1ρ1ρ3−4 da2didr3δ2ρ1ρ3+5 da2dr4δ2ρ32+dadi3dr2δ1ρ12+4 dadi3dr2δ1ρ1ρ3+8 dadi3dr2δ1ρ32−
2 dadi
2dr
3δ1ρ1ρ3 + 6 dadi
2dr
3δ2ρ1ρ3 + 5 dadidr
4δ1ρ3
2 + 8 di
2dr
4δ2ρ3
2
)
I∗2 + 4 dadidr2
(
2 da
3di
2δ2 +
da
3dr
2δ2+2 da
2di
3δ1+2 da
2didr
2δ1+2 dadi
2dr
2δ2+di
3dr
2δ1
))
T ∗reg+8 di
2ρ1
4ρ3
4I∗8−di2ρ12ρ32
(
5 da
2ρ1
2+
8 dadiρ1ρ3+12 dadrρ1ρ3+4 di
2ρ1
2+16 di
2ρ1ρ3+16 di
2ρ3
2−8 didrρ1ρ3+8 dr2ρ32
)
I∗6+2 di2ρ1ρ3
(
da
3diρ1
2+
3 da
3drρ1
2 + 2 da
2di
2ρ1
2 + 4 da
2di
2ρ1ρ3−da2didrρ12 + 5 da2dr2ρ1ρ3 + 2 dadi2drρ12 + 8 dadi2drρ32 +
4 dadidr
2ρ3
2+6 dadr
3ρ3
2+4 di
2dr
2ρ1ρ3+8 di
2dr
2ρ3
2−4 didr3ρ32
)
I∗4−di2
(
da
4di
2ρ1
2+2 da
4dr
2ρ1
2+
4 da
3di
2drρ1ρ3+2 da
3didr
2ρ1ρ3+6 da
3dr
3ρ1ρ3+2 da
2di
2dr
2ρ1
2+4 da
2di
2dr
2ρ1ρ3+8 da
2di
2dr
2ρ3
2−
2 da
2didr
3ρ1ρ3 + 5 da
2dr
4ρ3
2 + 4 dadi
2dr
3ρ1ρ3 + 4 di
2dr
4ρ3
2
)
I∗2 + 2 da2di2dr2
(
da
2di
2 + da
2dr
2 +
di
2dr
2
)
.
b4 = T
∗
reg
8δ1
4δ2
4 + 4 δ1
3δ2
3 (daδ2 + diδ1)T
∗
reg
7 +
(
− δ12δ22
(
2 δ1
2ρ1
2 + 2 δ1δ2ρ1
2 + 6 δ1δ2ρ1ρ3 +
δ2
2ρ1
2 + 4 δ2
2ρ3
2
)
I∗2 + 2 δ12δ22
(
3 da
2δ2
2 + 8 dadiδ1δ2 + 3 di
2δ1
2 + 2 dr
2δ1
2 + 2 dr
2δ2
2
))
T ∗reg
6 +(
− 2 δ1δ2
(
3 daδ1
2δ2ρ1
2 + 2 daδ1δ2
2ρ1
2 + 8 daδ1δ2
2ρ1ρ3 + 4 daδ2
3ρ3
2 + diδ1
3ρ1
2 + 3 diδ1
2δ2ρ1
2 +
8 diδ1
2δ2ρ1ρ3+diδ1δ2
2ρ1
2+2 diδ1δ2
2ρ1ρ3+8 diδ1δ2
2ρ3
2−drδ12δ2ρ1ρ3−2 drδ1δ22ρ1ρ3−2 drδ23ρ1ρ3
)
I∗2+
19
4 δ1δ2
(
da
3δ2
3 + 6 da
2diδ1δ2
2 + 6 dadi
2δ1
2δ2 + 4 dadr
2δ1
2δ2 + 2 dadr
2δ2
3 + di
3δ1
3 + 2 didr
2δ1
3 +
4 didr
2δ1δ2
2
))
T ∗reg
5 +
(
2 ρ3δ2ρ1
(
4 δ1
3ρ1
2 + 4 δ1
2δ2ρ1ρ3 − 2 δ1δ22ρ12 + 6 δ1δ22ρ1ρ3 + 4 δ1δ22ρ32 −
δ2
3ρ1ρ3 + 4 δ2
3ρ3
2
)
Y 4 +
(
− 7 da2δ12δ22ρ12 − 2 da2δ1δ23ρ12 − 14 da2δ1δ23ρ1ρ3 − 4 da2δ24ρ32 −
6 dadiδ1
3δ2ρ1
2−12 dadiδ12δ22ρ12−42 dadiδ12δ22ρ1ρ3+2 dadiδ1δ23ρ12−8 dadiδ1δ23ρ1ρ3−32 dadiδ1δ23ρ32+
2 dadrδ1
2δ2
2ρ1ρ3 + 8 dadrδ1δ2
3ρ1ρ3− di2δ14ρ12− 6 di2δ13δ2ρ12− 14 di2δ13δ2ρ1ρ3− 2 di2δ12δ22ρ12−
12 di
2δ1
2δ2
2ρ1ρ3−24 di2δ12δ22ρ32+10 didrδ12δ22ρ1ρ3+12 didrδ1δ23ρ1ρ3−dr2δ14ρ12−2 dr2δ13δ2ρ12−
6 dr
2δ1
3δ2ρ1ρ3−3 dr2δ12δ22ρ12−2 dr2δ12δ22ρ1ρ3−10 dr2δ12δ22ρ32−2 dr2δ1δ23ρ12−6 dr2δ1δ23ρ1ρ3−
8 dr
2δ2
4ρ3
2
)
I∗2+da4δ24+16 da3diδ1δ23+36 da2di2δ12δ22+24 da2dr2δ12δ22+4 da2dr2δ24+16 dadi3δ13δ2+
32 dadidr
2δ1
3δ2 + 32 dadidr
2δ1δ2
3 + di
4δ1
4 + 4 di
2dr
2δ1
4 + 24 di
2dr
2δ1
2δ2
2 + dr
4δ1
4 + 4 dr
4δ1
2δ2
2 +
dr
4δ2
4
)
T ∗reg
4 +
(
2 ρ3ρ1
(
10 daδ1
2δ2ρ1
2 − 2 daδ1δ22ρ12 + 8 daδ1δ22ρ1ρ3 + 4 daδ23ρ32 + 3 diδ13ρ12 +
3 diδ1
2δ2ρ1
2+6 diδ1
2δ2ρ1ρ3−2 diδ1δ22ρ12+20 diδ1δ22ρ1ρ3+12 diδ1δ22ρ32−2 diδ23ρ1ρ3+20 diδ23ρ32+
drδ1
3ρ1
2−2 drδ12δ2ρ12−5 drδ1δ22ρ12+3 drδ1δ22ρ32−4 drδ23ρ32
)
I∗4+
(
−4 da3δ1δ22ρ12−4 da3δ23ρ1ρ3−
8 da
2diδ1
2δ2ρ1
2−6 da2diδ1δ22ρ12−36 da2diδ1δ22ρ1ρ3−4 da2diδ23ρ1ρ3−16 da2diδ23ρ32−2 da2drδ1δ22ρ1ρ3+
4 da
2drδ2
3ρ1ρ3−4 dadi2δ13ρ12−12 dadi2δ12δ2ρ12−36 dadi2δ12δ2ρ1ρ3+2 dadi2δ1δ22ρ12−24 dadi2δ1δ22ρ1ρ3−
48 dadi
2δ1δ2
2ρ3
2−8 dadidrδ12δ2ρ1ρ3+20 dadidrδ1δ22ρ1ρ3−4 dadidrδ23ρ1ρ3−4 dadr2δ13ρ12−4 dadr2δ12δ2ρ12−
16 dadr
2δ1
2δ2ρ1ρ3−4 dadr2δ1δ22ρ12−4 dadr2δ1δ22ρ1ρ3−20 dadr2δ1δ22ρ32−4 dadr2δ23ρ1ρ3−2 di3δ13ρ12−
4 di
3δ1
3ρ1ρ3−2 di3δ12δ2ρ12−12 di3δ12δ2ρ1ρ3−16 di3δ12δ2ρ32−2 di2drδ13ρ1ρ3 +8 di2drδ12δ2ρ1ρ3 +
12 di
2drδ1δ2
2ρ1ρ3−2 didr2δ13ρ12−4 didr2δ13ρ1ρ3−4 didr2δ12δ2ρ12−8 didr2δ12δ2ρ1ρ3−20 didr2δ12δ2ρ32−
6 didr
2δ1δ2
2ρ1
2−16 didr2δ1δ22ρ1ρ3−4 didr2δ23ρ1ρ3−32 didr2δ23ρ32−2 dr3δ13ρ1ρ3+4 dr3δ12δ2ρ1ρ3+
2 dr
3δ1δ2
2ρ1ρ3 + 4 dr
3δ2
3ρ1ρ3
)
I∗2 + 4 da4diδ23 + 24 da3di2δ1δ22 + 16 da3dr2δ1δ22 + 24 di3δ12δ2da2 +
48 da
2didr
2δ1
2δ2 + 16 da
2didr
2δ2
3 + 4 dadi
4δ1
3 + 16 dadi
2δ1
3dr
2 + 48 dadi
2δ1dr
2δ2
2 + 4 dadr
4δ1
3 +
8 dadr
4δ1δ2
2 + 16 di
3δ1
2δ2dr
2 + 8 didr
4δ1
2δ2 + 4 didr
4δ2
3
)
T ∗reg
3 +
(
− ρ12ρ32
(
δ1
2ρ1
2 + 2 δ1δ2ρ1
2 +
6 δ1δ2ρ1ρ3 + δ2
2ρ1
2 + 2 δ2
2ρ1ρ3 + 5 δ2
2ρ3
2
)
I∗6 + 2 ρ3ρ1
(
8 da
2δ1δ2ρ1
2 − da2δ22ρ12 + 4 da2δ22ρ1ρ3 +
7 dadiδ1
2ρ1
2+2 dadiδ1δ2ρ1
2+14 dadiδ1δ2ρ1ρ3+2 dadiδ2
2ρ1
2+12 dadiδ2
2ρ3
2+3 dadrδ1
2ρ1
2−4 dadrδ1δ2ρ12−
dadrδ2
2ρ1
2+3 dadrδ2
2ρ3
2+4 di
2δ1
2ρ1
2+3 di
2δ1
2ρ1ρ3+4 di
2δ1δ2ρ1
2+22 di
2δ1δ2ρ1ρ3+12 di
2δ1δ2ρ3
2+
di
2δ2
2ρ1
2 +3 di
2δ2
2ρ1ρ3 +36 di
2δ2
2ρ3
2−didrδ12ρ12−7 didrδ1δ2ρ12 +9 didrδ1δ2ρ32−2 didrδ22ρ12−
12 didrδ2
2ρ3
2 + dr
2δ1
2ρ1ρ3 + 2 dr
2δ1δ2ρ1ρ3 + 2 dr
2δ1δ2ρ3
2 + 4 dr
2δ2
2ρ1ρ3 + 3 dr
2δ2
2ρ3
2
)
I∗4 +
(
−
da
4δ2
2ρ1
2− 6 da3diδ1δ2ρ12− 10 da3diδ22ρ1ρ3− 2 da3drδ22ρ1ρ3− 7 da2di2δ12ρ12− 6 da2di2δ1δ2ρ12−
30 da
2di
2δ1δ2ρ1ρ3 − 2 da2di2δ22ρ12 − 12 da2di2δ22ρ1ρ3 − 24 da2di2δ22ρ32 − 16 da2didrδ1δ2ρ1ρ3 +
10 da
2didrδ2
2ρ1ρ3−6 da2dr2δ12ρ12−2 da2dr2δ1δ2ρ12−14 da2dr2δ1δ2ρ1ρ3−2 da2dr2δ22ρ12−2 da2dr2δ22ρ1ρ3−
10 da
2dr
2δ2
2ρ3
2−4 dadi3δ12ρ12−10 dadi3δ12ρ1ρ3−2 dadi3δ1δ2ρ12−24 dadi3δ1δ2ρ1ρ3−32 dadi3δ1δ2ρ32−
10 dadi
2drδ1
2ρ1ρ3 +16 dadi
2drδ1δ2ρ1ρ3−12 dadi2drδ22ρ1ρ3−4 dadidr2δ12ρ12−10 dadidr2δ12ρ1ρ3−
6 dadidr
2δ1δ2ρ1
2 − 16 dadidr2δ1δ2ρ1ρ3 − 40 dadidr2δ1δ2ρ32 − 10 dadidr2δ22ρ1ρ3 − 6 dadr3δ12ρ1ρ3 +
8 dadr
3δ1δ2ρ1ρ3−2 dadr3δ22ρ1ρ3−di4δ12ρ12−4 di4δ12ρ1ρ3−4 di4δ12ρ32+2 di3drδ12ρ1ρ3+4 di3drδ1δ2ρ1ρ3−
3 di
2dr
2δ1
2ρ1
2−6 di2dr2δ12ρ1ρ3−10 di2dr2δ12ρ32−6 di2dr2δ1δ2ρ12−14 di2dr2δ1δ2ρ1ρ3−di2dr2δ22ρ12−
12 di
2dr
2δ2
2ρ1ρ3−48 di2dr2δ22ρ32+2 didr3δ12ρ1ρ3+10 didr3δ22ρ1ρ3−dr4δ12ρ32−5 dr4δ22ρ32
)
I∗2+
6 da
4di
2δ2
2+4 da
4dr
2δ2
2+16 da
3di
3δ1δ2+32 da
3didr
2δ1δ2+6 da
2di
4δ1
2+24 da
2di
2dr
2δ1
2+24 da
2di
2dr
2δ2
2+
6 da
2dr
4δ1
2+4 da
2dr
4δ2
2+32 dadi
3dr
2δ1δ2+16 dadidr
4δ1δ2+4 di
4dr
2δ1
2+4 di
2dr
4δ1
2+6 di
2dr
4δ2
2
)
T ∗reg
2+(
−2 ρ12ρ32
(
daδ1ρ1
2+2 daδ2ρ1ρ3+diδ1ρ1
2+2 diδ1ρ1ρ3+2 diδ2ρ1
2+6 diδ2ρ1ρ3+6 diδ2ρ3
2+drδ1ρ1ρ3−
2 drδ2ρ1ρ3
)
I∗6 + 2 ρ3ρ1
(
2 da
3δ2ρ1
2 + 5 da
2diδ1ρ1
2 + da
2diδ2ρ1
2 + 8 da
2diδ2ρ1ρ3 + 3 da
2drδ1ρ1
2 −
2 da
2drδ2ρ1
2+6 dadi
2δ1ρ1
2+8 dadi
2δ1ρ1ρ3+4 dadi
2δ2ρ1
2+12 dadi
2δ2ρ3
2−2 dadidrδ1ρ12+dadidrδ2ρ12+
9 dadidrδ2ρ3
2 + 2 dadr
2δ1ρ1ρ3 + 2 dadr
2δ2ρ3
2 + 3 di
3δ1ρ1
2 + 8 di
3δ1ρ1ρ3 + 4 di
3δ1ρ3
2 + 3 di
3δ2ρ1
2 +
8 di
3δ2ρ1ρ3+28 di
3δ2ρ3
2−di2drδ1ρ12+6 di2drδ1ρ32−4 di2drδ2ρ12−12 di2drδ2ρ32+2 didr2δ1ρ1ρ3+
didr
2δ1ρ3
2+8 didr
2δ2ρ1ρ3+9 didr
2δ2ρ3
2+dr
3δ1ρ3
2−2 dr3δ2ρ32
)
I∗4+
(
−2 da4diδ2ρ12−6 da3di2δ1ρ12−
8 da
3di
2δ2ρ1ρ3−8 da3didrδ2ρ1ρ3−4 da3dr2δ1ρ12−4 da3dr2δ2ρ1ρ3−2 da2di3δ1ρ12−8 da2di3δ1ρ1ρ3−
20
4 da
2di
3δ2ρ1
2−12 da2di3δ2ρ1ρ3−16 da2di3δ2ρ32−14 da2di2drδ1ρ1ρ3+8 da2di2drδ2ρ1ρ3−2 da2didr2δ1ρ12−
8 da
2didr
2δ1ρ1ρ3−4 da2didr2δ2ρ12−8 da2didr2δ2ρ1ρ3−20 da2didr2δ2ρ32−6 da2dr3δ1ρ1ρ3+4 da2dr3δ2ρ1ρ3−
2 dadi
4δ1ρ1
2−8 dadi4δ1ρ1ρ3−8 dadi4δ1ρ32+4 dadi3drδ1ρ1ρ3−12 dadi3drδ2ρ1ρ3−6 dadi2dr2δ1ρ12−
12 dadi
2dr
2δ1ρ1ρ3−20 dadi2dr2δ1ρ32−8 dadi2dr2δ2ρ1ρ3+4 dadidr3δ1ρ1ρ3−8 dadidr3δ2ρ1ρ3−2 dadr4δ1ρ32−
2 di
3dr
2δ1ρ1
2−4 di3dr2δ1ρ1ρ3−2 di3dr2δ2ρ12−12 di3dr2δ2ρ1ρ3−32 di3dr2δ2ρ32−2 di2dr3δ1ρ1ρ3 +
8 di
2dr
3δ2ρ1ρ3−10 didr4δ2ρ32
)
I∗2+4 da4di3δ2+8 da4didr2δ2+4 da3di4δ1+16 da3di2dr2δ1+4 da3dr4δ1+
16 da
2di
3dr
2δ2+8 da
2didr
4δ2+8 dadi
4dr
2δ1+8 dadi
2dr
4δ1+4 di
3dr
4δ2
)
T ∗reg+I
∗8ρ14ρ34−ρ12ρ32
(
da
2ρ1
2+
2 dadiρ1ρ3+2 dadrρ1ρ3+5 di
2ρ1
2+12 di
2ρ1ρ3+8 di
2ρ3
2−2 didrρ1ρ3+dr2ρ32
)
I∗6+2 ρ3ρ1
(
da
3diρ1
2+
da
3drρ1
2+3 da
2di
2ρ1
2+5 da
2di
2ρ1ρ3−da2didrρ12+da2dr2ρ1ρ3+dadi3ρ12+4 dadi3ρ32+3 dadi2drρ12+
6 dadi
2drρ3
2 + dadidr
2ρ3
2 + dadr
3ρ3
2 + 2 di
4ρ1
2 + 4 di
4ρ1ρ3 + 8 di
4ρ3
2 − di3drρ12 − 4 di3drρ32 +
5 di
2dr
2ρ1ρ3+6 di
2dr
2ρ3
2−didr3ρ32
)
I∗4+
(
−2 da4di2ρ12−da4dr2ρ12−2 da3di3ρ1ρ3−6 da3di2drρ1ρ3−
2 da
3didr
2ρ1ρ3−2 da3dr3ρ1ρ3−2 da2di4ρ12−4 da2di4ρ1ρ3−4 da2di4ρ32+2 da2di3drρ1ρ3−4 da2di2dr2ρ12−
6 da
2di
2dr
2ρ1ρ3− 10 da2di2dr2ρ32 + 2 da2didr3ρ1ρ3− da2dr4ρ32− 4 dadi4drρ1ρ3− 2 dadi3dr2ρ1ρ3−
6 dadi
2dr
3ρ1ρ3−di4dr2ρ12− 4 di4dr2ρ1ρ3− 8 di4dr2ρ32 + 2 di3dr3ρ1ρ3− 5 di2dr4ρ32
)
I∗2 +da4di4 +
4 da
4di
2dr
2 + da
4dr
4 + 4 da
2di
4dr
2 + 4 da
2di
2dr
4 + di
4dr
4.
b6 = 2 δ1
2δ2
2
(
δ1
2+δ2
2
)
T ∗reg
6+4 δ1δ2
(
2 daδ1
2δ2+daδ2
3+diδ1
3+2 diδ1δ2
2
)
T ∗reg
5+
((
−δ14ρ12−
2 δ1
3δ2ρ1
2 − 6 δ13δ2ρ1ρ3 − 3 δ12δ22ρ12 − 2 δ12δ22ρ1ρ3 − 5 δ12δ22ρ32 − 2 δ1δ23ρ12 − 6 δ1δ23ρ1ρ3 −
4 δ2
4ρ3
2
)
I∗2+12 da2δ12δ22+2 da2δ24+16 dadiδ13δ2+16 dadiδ1δ23+2 di2δ14+12 di2δ12δ22+2 dr2δ14+
8 dr
2δ1
2δ2
2 + 2 dr
2δ2
4
)
T ∗reg
4 +
((
− 4 daδ13ρ12 − 4 daδ12δ2ρ12 − 16 daδ12δ2ρ1ρ3 − 4 daδ1δ22ρ12 −
4 daδ1δ2
2ρ1ρ3−10 daδ1δ22ρ32−4 daδ23ρ1ρ3−2 diδ13ρ12−4 diδ13ρ1ρ3−4 diδ12δ2ρ12−8 diδ12δ2ρ1ρ3−
10 diδ1
2δ2ρ3
2−6 diδ1δ22ρ12−16 diδ1δ22ρ1ρ3−4 diδ23ρ1ρ3−16 diδ23ρ32−2 drδ13ρ1ρ3+4 drδ12δ2ρ1ρ3+
2 drδ1δ2
2ρ1ρ3+4 drδ2
3ρ1ρ3
)
I∗2+8 da3δ1δ22+24 da2diδ12δ2+8 da2diδ23+8 dadi2δ13+24 dadi2δ1δ22+
8 dadr
2δ1
3+16 dadr
2δ1δ2
2+8 di
3δ1
2δ2+16 didr
2δ1
2δ2+8 didr
2δ2
3
)
T ∗reg
3+
(
2 ρ1ρ3
(
δ1
2ρ1
2+δ1
2ρ1ρ3+
4 δ1δ2ρ1
2+2 δ1δ2ρ1ρ3+2 δ1δ2ρ3
2−δ22ρ12+4 δ22ρ1ρ3+3 δ22ρ32
)
I∗4+
(
−6 da2δ12ρ12−2 da2δ1δ2ρ12−
14 da
2δ1δ2ρ1ρ3−2 da2δ22ρ12−2 da2δ22ρ1ρ3−5 da2δ22ρ32−4 dadiδ12ρ12−10 dadiδ12ρ1ρ3−6 dadiδ1δ2ρ12−
16 dadiδ1δ2ρ1ρ3−20 dadiδ1δ2ρ32−10 dadiδ22ρ1ρ3−6 dadrδ12ρ1ρ3+8 dadrδ1δ2ρ1ρ3−2 dadrδ22ρ1ρ3−
3 di
2δ1
2ρ1
2−6 di2δ12ρ1ρ3−5 di2δ12ρ32−6 di2δ1δ2ρ12−14 di2δ1δ2ρ1ρ3−di2δ22ρ12−12 di2δ22ρ1ρ3−
24 di
2δ2
2ρ3
2+2 didrδ1
2ρ1ρ3+10 didrδ2
2ρ1ρ3−2 dr2δ12ρ12−2 dr2δ12ρ1ρ3−2 dr2δ12ρ32−2 dr2δ1δ2ρ12−
6 dr
2δ1δ2ρ1ρ3−dr2δ22ρ12−2 dr2δ22ρ1ρ3−10 dr2δ22ρ32
)
I∗2+2 da4δ22+16 da3diδ1δ2+12 da2di2δ12+
12 da
2di
2δ2
2 + 12 da
2dr
2δ1
2 + 8 da
2dr
2δ2
2 + 16 dadi
3δ1δ2 + 32 dadidr
2δ1δ2 + 2 di
4δ1
2 + 8 di
2dr
2δ1
2 +
12 di
2dr
2δ2
2 + 2 dr
4δ1
2 + 2 dr
4δ2
2
)
T ∗reg
2 +
(
2 ρ1ρ3
(
2 daδ1ρ1
2 + 2 daδ1ρ1ρ3 + 2 daδ2ρ1
2 + 2 daδ2ρ3
2 +
3 diδ1ρ1
2 + 2 diδ1ρ1ρ3 + diδ1ρ3
2 + diδ2ρ1
2 + 8 diδ2ρ1ρ3 + 9 diδ2ρ3
2 + drδ1ρ1
2 + drδ1ρ3
2− 2 drδ2ρ12−
2 drδ2ρ3
2
)
I∗4+
(
−4 da3δ1ρ12−4 da3δ2ρ1ρ3−2 da2diδ1ρ12−8 da2diδ1ρ1ρ3−4 da2diδ2ρ12−8 da2diδ2ρ1ρ3−
10 da
2diδ2ρ3
2 − 6 da2drδ1ρ1ρ3 + 4 da2drδ2ρ1ρ3 − 6 dadi2δ1ρ12 − 12 dadi2δ1ρ1ρ3 − 10 dadi2δ1ρ32 −
8 dadi
2δ2ρ1ρ3 + 4 dadidrδ1ρ1ρ3 − 8 dadidrδ2ρ1ρ3 − 4 dadr2δ1ρ12 − 4 dadr2δ1ρ1ρ3 − 4 dadr2δ1ρ32 −
4 dadr
2δ2ρ1ρ3− 2 di3δ1ρ12− 4 di3δ1ρ1ρ3− 2 di3δ2ρ12− 12 di3δ2ρ1ρ3− 16 di3δ2ρ32− 2 di2drδ1ρ1ρ3 +
8 di
2drδ2ρ1ρ3−2 didr2δ1ρ12−4 didr2δ1ρ1ρ3−2 didr2δ2ρ12−8 didr2δ2ρ1ρ3−20 didr2δ2ρ32−2 dr3δ1ρ1ρ3+
4 dr
3δ2ρ1ρ3
)
Y 2 + 4 da
4diδ2 + 8 da
3di
2δ1 + 8 da
3dr
2δ1 + 8 da
2di
3δ2 + 16 da
2didr
2δ2 + 4 dadi
4δ1 +
16 dadi
2dr
2δ1 + 4 dadr
4δ1 + 8 di
3dr
2δ2 + 4 didr
4δ2
)
T ∗reg − ρ12ρ32
(
ρ1 + ρ3
)2
I∗6 + 2 ρ1ρ3
(
da
2ρ1
2 +
da
2ρ1ρ3 + dadiρ1
2 + dadiρ3
2 + dadrρ1
2 + dadrρ3
2 + 3 di
2ρ1
2 + 5 di
2ρ1ρ3 + 6 di
2ρ3
2 − didrρ12 −
didrρ3
2+dr
2ρ1ρ3+dr
2ρ3
2
)
Y 4+
(
−da4ρ12−2 da3diρ1ρ3−2 da3drρ1ρ3−4 da2di2ρ12−6 da2di2ρ1ρ3−
5 da
2di
2ρ3
2+2 da
2didrρ1ρ3−2 da2dr2ρ12−2 da2dr2ρ1ρ3−2 da2dr2ρ32−2 dadi3ρ1ρ3−6 dadi2drρ1ρ3−
2 dadidr
2ρ1ρ3−2 dadr3ρ1ρ3−di4ρ12−4 di4ρ1ρ3−4 di4ρ32+2 di3drρ1ρ3−2 di2dr2ρ12−6 di2dr2ρ1ρ3−
21
10 di
2dr
2ρ3
2 + 2 didr
3ρ1ρ3 − dr4ρ32
)
I∗2 + 2 da4di2 + 2 da4dr2 + 2 da2di4 + 8 da2di2dr2 + 2 da2dr4 +
2 di
4dr
2 + 2 di
2dr
4.
b8 =
(
δ1
4+4 δ1
2δ2
2+δ2
4
)
T ∗reg
4+
(
4 daδ1
3+8 daδ1δ2
2+8 diδ1
2δ2+4 diδ2
3
)
T ∗reg
3+
((
−2 δ12ρ12−
2 δ1
2ρ1ρ3−δ12ρ32−2 δ1δ2ρ12−6 δ1δ2ρ1ρ3−δ22ρ12−2 δ22ρ1ρ3−5 δ22ρ32
)
I∗2 +6 da2δ12+4 da2δ22+
16 dadiδ1δ2+4 di
2δ1
2+6 di
2δ2
2+4 dr
2δ1
2+4 dr
2δ2
2
)
T ∗reg
2+
((
−4 daδ1ρ12−4 daδ1ρ1ρ3−2 daδ1ρ32−
4 daδ2ρ1ρ3−2 diδ1ρ12−4 diδ1ρ1ρ3−2 diδ2ρ12−8 diδ2ρ1ρ3−10 diδ2ρ32−2 drδ1ρ1ρ3+4 drδ2ρ1ρ3
)
I∗2+
4 da
3δ1 +8 da
2diδ2 +8 dadi
2δ1 +8 dadr
2δ1 +4 di
3δ2 +8 didr
2δ2
)
T ∗reg+2 ρ1ρ3
(
ρ1
2 +ρ3ρ1 +ρ3
2
)
I∗4 +(
− 2 da2ρ12 − 2 da2ρ1ρ3 − da2ρ32 − 2 dadiρ1ρ3 − 2 dadrρ1ρ3 − 2 di2ρ12 − 6 di2ρ1ρ3 − 5 di2ρ32 +
2 didrρ1ρ3 − dr2ρ12 − 2 dr2ρ1ρ3 − 2 dr2ρ32
)
I∗2 + da4 + 4 da2di2 + 4 da2dr2 + di4 + 4 di2dr2 + dr4.
b10 =
(
2 δ1
2 + 2 δ2
2
)
T ∗reg
2 +
(
4 daδ1 + 4 diδ2
)
Treg∗ −
(
ρ1 + ρ3
)2
I∗2 + 2 da2 + 2 di2 + 2 dr2.
References
[1] Mason, D., A very high level of crossreactivity is an essential feature of the T-cell receptor,
Immunol. Today 1998, 19, 395–404.
[2] Anderson, A.C.; Waldner, H.; Turchin, V.; Jabs, C.; Prabhu Das, M.; Kuchroo, V.K.;
Nicholson, L.B., Autoantigen responsive T cell clones demonstrate unfocused TCR cross-
reactivity towards multiple related ligands: Implications for autoimmunity, Cell. Immunol.
2000, 202, 88–96.
[3] Kerr, E.C.; Copland, D.A.; Dick, A.D.; Nicholson, L.B., The dynamics of leukocyte infiltra-
tion in experimental autoimmune uveoretinitis, Prog. Retin. Eye Res. 2008, 27, 527–535.
[4] Prat, E.; Martin, R., The immunopathogenesis of multiple sclerosis, J. Rehabil. Res. Dev.
2002, 39, 187–200.
[5] Santamaria, P., The long and winding road to understanding and conquering type 1 diabetes,
Immunity 2010, 32, 437–445.
[6] Root-Bernstein, R.; Fairweather, D., Unresolved issues in theories of autoimmune disease
using myocarditis as a framework, J. Theor. Biol. 2015, 375, 101–123.
[7] Caforio, A.L.P.; Iliceto, S., Genetically determined myocarditis: Clinical presentation and
immunological characteristics, Curr. Opin. Cardiol. 2008, 23, 219–226.
[8] Li, H.S.; Ligons, D.L.; Rose, N.R., Genetic complexity of autoimmune myocarditis, Autoim-
mun. Rev. 2008, 7, 168–173.
[9] Guilherme, L.; Ko¨hler, K.F.; Postol, E.; Kalil, J., Genes, autoimmunity and pathogenesis
of rheumatic heart disease, Ann. Pediatr. Cardiol. 2011, 4, 13–21.
[10] Germolic, D.; Kono, D.H.; Pfau, J.C.; Pollard, K.M., Animal models used to examine the
role of environment in the development of autoimmune disease: Findings from an NIEHS
Expert Panel Workshop, J. Autoimmun. 2012, 39, 285–293.
[11] Mallampalli, M.P.; Davies, E.; Wood, D.; Robertson, H.; Polato, F.; Carter, C.L., Role of
environment and sex differences in the development of autoimmune disease: A roundtable
meeting report, J. Women’s Health 2013, 22, 578–586.
[12] Manfredo Vieira, S.; Hiltensperger, M.; Kumar, V.; Zegarra-Ruiz, D.; Dehne, C.; Khan, N.;
Costa, F.R.C.; Tiniakou, E.; Greiling, T.; et al., Translocation of a gut pathobiont drives
autoimmunity in mice and humans, Science 2018, 359, 1156–1161.
[13] Fujinami, R.S., Can virus infections trigger autoimmune disease? J. Autoimmun. 2001,
16, 229–234.
22
[14] Von Herrath, M.G.; Oldstone, M.B.A., Virus-induced autoimmune disease, Curr. Opin.
Immunol. 1996, 8, 878–885.
[15] Ercolini, A.M.; Miller, S.D.,The role of infections in autoimmune disease, Clin. Exp. Im-
munol. 2009, 155, 1–15.
[16] Segel, L.A.; Ja¨ger, E.; Elias, D.; Cohen, I.R., A quantitative model of autoimmune disease
and T-cell vaccination: Does more mean less? Immunol. Today 1995, 16, 80–84.
[17] Borghans, J.A.M.; De Boer, R.J., A minimal model for T-cell vaccination, Proc. R. Soc.
Lond. B Biol. Sci. 1995, 259, 173–178.
[18] Borghans, J.A.M.; De Boer, R.J.; Sercarz, E.; Kumar, V., T cell vaccination in experimental
autoimmune encephalomyelitis: A mathematical model, J. Immunol. 1998, 161, 1087–1093.
[19] Leo´n, K.; Perez, R.; Lage, A.; Carneiro, J., Modelling T-cell-mediated suppression depen-
dent on interactions in multicellular conjugates, J. Theor. Biol. 2000, 207, 231–254.
[20] Leo´n, K.; Lage, A.; Carneiro, J., Tolerance and immunity in a mathematical model of T-cell
mediated suppression, J. Theor. Biol. 2003, 225, 107–126.
[21] Leo´n, K.; Faro, J.; Lage, A.; Carneiro, J., Inverse correlation between the incidences of
autoimmune disease and infection predicted by a model of T cell mediated tolerance, J.
Autoimmun. 2004, 22, 31–42.
[22] Carneiro, J.; Paixa˜o, T.; Milutinovic, D.; Sousa, J.; Leon, K.; Gardner, R.; Faro, J., Im-
munological self-tolerance: Lessons from mathematical modeling, J. Comput. Appl. Math.
2005, 184, 77–100.
[23] Alexander, H.K.; Wahl, L.M., Self-tolerance and autoimmunity in a regulatory T cell model,
Bull. Math. Biol. 2011, 73, 33–71.
[24] Iwami, S.; Takeuchi, Y.; Miura, Y.; Sasaki, T.; Kajiwara, T., Dynamical properties of
autoimmune disease models: Tolerance, flare-up, dormancy, J. Theor. Biol. 2007, 246, 646–
659.
[25] Iwami, S.; Takeuchi, Y.; Iwamoto, K.; Naruo, Y.; Yasukawa, M., A mathematical design of
vector vaccine against autoimmune disease, J. Theor. Biol. 2009, 256, 382–392.
[26] Burroughs, N.J.; Ferreira, M.; Oliveira, B.M.P.M.; Pinto, A.A., Autoimmunity arising from
bystander proliferation of T cells in an immune response model, Math. Comput. Model.
2011, 53, 1389–1393.
[27] Burroughs, N.J.; Ferreira, M.; Oliveira, B.M.P.M.; Pinto, A.A., A transcritical bifurcation
in an immune response model, J. Differ. Equ. Appl. 2011, 17, 1101–1106.
[28] Burroughs, N.J.; de Oliveira, B.M.P.M.; Pinto, A.A., Regulatory T cell adjustment of quo-
rum growth thresholds and the control of local immune responses, J. Theor. Biol. 2006,
241, 134–141.
[29] Sakaguchi, S., Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and
negative control of immune responses, Ann. Rev. Immunol. 2004, 22, 531–562.
[30] Josefowicz, S.Z.; Lu, L.F.; Rudensky, A.Y., Regulatory T cells: Mechanisms of differentia-
tion and function, Ann. Rev. Immunol. 2012, 30, 531–564.
[31] Fontenot, J.D.; Gavin, M.A.; Rudensky, A.Y., Foxp3 programs the development and func-
tion of CD4+CD25+ regulatory T cells, Nat. Immunol. 2003, 4, 330–336.
[32] Khattri, R.; Cox, T.; Yasayko, S.A.; Ramsdell, F., An essential role for Scurfin in
CD4+CD25+ T regulatory cells, Nat. Immunol. 2003, 4, 337–342.
[33] Grossman, Z.; Paul, W.E., Adaptive cellular interactions in the immune system: The tunable
activation threshold and the significance of subthreshold responses, Proc. Natl. Acad. Sci.
USA 1992, 89, 10365–10369.
[34] Grossman, Z.; Paul, W.E., Self-tolerance: Context dependent tuning of T cell antigen recog-
nition, Semin. Immunol. 2000, 12, 197–203.
23
[35] Grossman, Z.; Singer, A., Tuning of activation thresholds explains flexibility in the selection
and development of T cells in the thymus, Proc. Natl. Acad. Sci. USA 1996, 93, 14747–
14752.
[36] Altan-Bonnet, G.; Germain, R.N., Modeling T cell antigen discrimination based on feedback
control of digital ERK responses, PLoS Biol. 2005, 3, e356.
[37] Bitmansour, A.D.; Douek, D.C.; Maino, V.C.; Picker, L.J., Direct ex vivo analysis of human
CD4+ memory T cell activation requirements at the single clonotype level, J. Immunol.
2002, 169, 1207–1218.
[38] Nicholson, L.B.; Anderson, A.C.; Kuchroo, V.K., Tuning T cell activation threshold and
effector function with cross-reactive peptide ligands, Int. Immunol. 2000, 12, 205–213.
[39] Ro¨mer, P.S.; Berr, S.; Avota, E.; Na, S.Y.; Battaglia, M.; ten Berge, I.; Einsele, H.; Hu¨nig,
T., Preculture of PBMC at high cell density increases sensitivity of T-cell responses, reveal-
ing cytokine release by CD28 superagonist TGN1412, Blood 2011, 118, 6772–6782.
[40] Stefanova´, I.; Dorfman, J.R.; Germain, R.N., Self-recognition promotes the foreign antigen
sensitivity of naive T lymphocytes, Nature 2002, 420, 429–434.
[41] van den Berg, H.A.; Rand, D.A., Dynamics of T cell activation threshold tuning, J. Theor.
Biol. 2004, 228, 397–416.
[42] Scherer, A.; Noest, A.; de Boer, R.J., Activation-threshold tuning in an affinity model for
the T-cell repertoire, Proc. R. Soc. B 2004, 271, 609–616.
[43] Blyuss, K.B.; Nicholson, L.B., The role of tunable activation thresholds in the dynamics of
autoimmunity, J. Theor. Biol. 2012, 308, 45–55.
[44] Blyuss, K.B.; Nicholson, L.B., Understanding the roles of activation threshold and infections
in the dynamics of autoimmune disease, J. Theor. Biol. 2015, 375, 13–20.
[45] Ben Ezra, D.; Forrester, J.V., Fundal white dots: The spectrum of a similar pathological
process, Br. J. Ophthalmol. 1995, 79, 856–860.
[46] Davies, T.F.; Evered, D.C.; Rees Smith, B.; Yeo, P.P.B.; Clark, F.; Hall, R., Value of
thyroid-stimulating-antibody determinations in predicting the short-term thyrotoxic relapse
in Graves’ disease, Lancet 1977, 309, 1181–1182.
[47] Nylander, A.; Hafler, D.A., Multiple sclerosis, J. Clin. Investig. 2012, 122, 1180–1188.
[48] Fatehi, F.; Kyrychko, Y.N.; Blyuss, K.B., Interactions between cytokines and T cells in the
dynamics of autoimmunity, 2018, submitted.
[49] Fatehi, F.; Kyrychko, S.N.; Ross, A.; Kyrychko, Y.N.; Blyuss, K.B., Stochastic effects in
autoimmune dynamics, Front. Physiol. 2018, 9, 45.
[50] Wu, H.J.; Ivanov, I.I.; Darce, J.; Hattori, K.; Shima, T.; Umesaki, Y.; Littman, D.R.;
Benoist, C.; Mathis, D., Gut-residing segmented filamentous bacteria drive autoimmune
arthritis via T helper 17 cells, Immunity 2010, 32, 815–827.
[51] Wolf, S.D.; Dittel, B.N.; Hardardottir, F.; Janeway, C.A., Experimental autoimmune en-
cephalomyelitis induction in genetically B cell-deficient mice, J. Exp. Med. 1996, 184, 2271–
2278.
[52] Baltcheva, I.; Codarri, L.; Pantaleo, G.; Le Boudec, J.Y., Lifelong dynamics of human
CD4+CD25+ regulatory T cells: Insights from in vivo data and mathematical modeling, J.
Theor. Biol. 2010, 266, 307–322.
[53] Shevach, E.M.; McHugh, R.S.; Piccirillo, C.A.; Thornton, A.M., Control of T-cell activation
by CD4+ CD25+ suppressor T cells, Immunol. Rev. 2001, 182, 58–67.
[54] Abbas, A.K.; Lichtman, A.H.; Pillai, S., Cellular and Molecular Immunology; Elsevier:
Philadelphia, USA, 2015.
[55] Thornton, A.M.; Shevach, E.M., CD4+CD25+ immunoregulatory T cells suppress polyclonal
T cell activation in vitro by inhibiting interleukin 2 production, J. Exp. Med. 1998, 188, 287–
296.
24
[56] Baccam, P.; Beauchemin, C.; Macken, C.A.; Hayden, F.G.; Perelson, A.S, Kinetics of in-
fluenza A virus infection in humans, J. Virol. 2006, 80, 7590–7599.
[57] Pawelek, K.A.; Huynh, G.T.; Quinlivan, M.; Cullinane, A.; Rong, L.; Perelson, A.S., Mod-
eling within-host dynamics of influenza virus infection including immune responses, PLoS
Comput. Biol. 2012, 8, e1002588.
[58] Kim, P.S.; Lee, P.P.; Levy, D., Modeling regulation mechanisms in the immune system, J.
Theor. Biol. 2007, 246, 33–69.
[59] Li, J.; Zhang, L.; Wang, Z., Two effective stability criteria for linear time-delay systems
with complex coefficients, J. Syst. Sci. Complex. 2011, 24, 835.
[60] Rahman, B.; Blyuss, K.B.; Kyrychko, Y.N., Dynamics of neural systems with discrete and
distributed time delays, SIAM J. Appl. Dyn. Syst. 2015, 14, 2069–2095.
[61] Breda, D.; Maset, S.; Vermiglio, R., Numerical computation of characteristic multipliers for
linear time periodic coefficients delay differential equations, IFAC Proc. Vol. 2006, 39, 163–
168.
[62] Kuznetsov, Y.A., Elements of Applied Bifurcation Theory; Springer-Verlag: New York, NY,
USA, 1995.
[63] Cavoretto, R.; Rossi, A.D.; Perracchione, E.; Venturino, E., Reliable approximation of
separatrix manifolds in competition models with safety niches, Int. J. Comput. Math. 2015,
92, 1826–1837.
[64] Cavoretto, R.; De Rossi, A.; Perracchione, E.; Venturino, E., Robust approximation algo-
rithms for the detection of attraction basins in dynamical systems, J. Sci. Comput. 2016,
68, 395–415.
[65] De Rossi, A.; Perracchione, E.; Venturino, E., Fast strategy for PU interpolation: An
application for the reconstruction of separatrix manifolds, Dolomites Res. Notes Approx.
2016, 9, 3–12.
[66] Francomano, E.; Hilker, F.M.; Paliaga, M.; Venturino, E., On basins of attraction for a
predator-prey model via meshless approximation, In AIP Conference Proceedings; AIP Pub-
lishing: Melville, NY, USA, 2016; Volume 1776, p. 070007.
[67] Cavoretto, R.; De Rossi, A.; Perracchione, E.; Venturino, E., Graphical representation of
separatrices of attraction basins in two and three-dimensional dynamical systems, Int. J.
Comput. Methods 2017, 14, 1750008.
[68] Francomano, E.; Hilker, F.M.; Paliaga, M.; Venturino, E., Separatrix reconstruction to
identify tipping points in an eco-epidemiological model, Appl. Math. Comput. 2018, 318, 80–
91.
[69] Skapenko, A.; Leipe, J.; Lipsky, P.E.; Schulze-Koops, H., The role of the T cell in autoim-
mune inflammation, Arthritis Res. Ther. 2005, 7 (Suppl. 2), S4–S14.
[70] Antia, R.; Ganusov, V.V.; Ahmed, R., The role of models in understanding CD8+ T-cell
memory, Nat. Rev. Immunol. 2005, 5, 101–111.
[71] Schluns, K.S.; Kieper, W.C.; Jameson, S.C.; Lefrancois, L., Interleukin-7 mediates the
homeostasis of na¨ıve and memory CD8 T cells in vivo, Nat. Immunol. 2000, 1, 426–432.
[72] Fatehi Chenar, F.; Kyrychko, Y.N.; Blyuss, K.B., Mathematical model of immune response
to hepatitis B, J. Theor. Biol. 2018, 447, 98–110.
[73] Perelson, A.S.; Weisbuch, G., Immunology for physicists, Rev. Mod. Phys. 1997, 69, 1219–
1267.
25
